データから考える 不妊症・不育症治療 改訂第2版

出版社: メジカルビュー社
著者:
発行日: 2022-08-10
分野: 臨床医学:外科  >  産婦人科学
ISBN: 9784758321426
電子書籍版: 2022-08-10 (第2版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

14,300 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

14,300 円(税込)

商品紹介

不妊症・不育症について,産婦人科医として知っておかなければいけない知識や患者への説明を行ううえで参考となるデータをもとに解説。各論部分では,順天堂大学および関連施設で実際に行われている基本方針に則った系統的な治療について詳細に解説し,かつ患者によく理解できる説明用のグラフ・イラスト・画像を豊富に用い,またQ&A部分はそのまま患者にみせることができるように,平易な記載部分と,同じ問いに対する詳細な医療者向けの解説を掲載している。
改訂にあたっては最新データに基づいてアップデートした上で,卵巣機能障害,慢性子宮内膜炎,黄体補充療法,不妊治療における保険・自費診療および助成制度,プレコンセプションケア等を追加,また着床前スクリーニングも新たな概念で全面刷新された。
患者に見せやすく医療者にも使いやすい,外来でそのまま使える書籍。

目次

  • 総論 なぜ不妊症・不育症になるのか?
     生殖医療の背景
      女性のライフスタイルの変化
      プレコンセプションケア
      女性妊孕能に及ぼすエイジングの影響
      卵巣予備能に影響するリスク因子
     不妊治療に必要な基礎知識
      婦人科内分泌の基礎知識
      月経周期
      妊娠の成立
      不妊症の原因
      不妊治療の基本指針
      男性生殖の基本
     不育症・習慣流産の基礎知識
      流産について
      不育症のリスク因子
      不育症治療の基本指針

    総論 Q & A
      妊娠前の準備
      年齢ごとの妊娠率
      年齢ごとの流産率,ダウン症候群発症率
      その他,妊娠に伴う合併症の発症率
      流産と染色体異常

    各論1 不妊治療の実際—どのように妊娠に導くのか?
      不妊治療のスケジュール
      排卵予測
     不妊治療に用いられる薬剤
      排卵誘発剤 クエン酸クロミフェン,アロマターゼ阻害薬,hMG/FSH 製剤,
      GnRH アゴニスト製剤,GnRH アンタゴニスト製剤,hCG 製剤
      その他 ドーパミン作動薬,エストロゲン製剤,プロゲスチン製剤
     妊娠方法
      タイミング法・配偶者間人工授精(AIH)・生殖補助医療(ART)
      妊娠方法別の妊娠率
     生殖補助医療
      卵巣刺激法
      採卵
      体外受精
      顕微受精(ICSI)
      ピエゾICSI
      黄体補充
      胚移植
      胚・配偶子・卵巣組織凍結保存
      着床前診断(PGT-A,PGT-SR)
      単一遺伝子疾患の着床前診断(PGT-M)
      不妊治療における保険診療および先進医療制度

    各論2 疾患別の治療
     不妊症
      子宮内膜症
      子宮筋腫
      子宮腺筋症
      子宮腔内病変
      多嚢胞性卵巣症候群(PCOS)
      低ゴナドトロピン性性腺機能低下症もしくは不全症
      早発卵巣不全(premature ovarian insufficiency;POI)
      原因不明不妊症
      column:反復着床不全に対するOPTIMUMstrategy
      男性不妊症
      卵管機能障害
      慢性子宮内膜炎
     不育症
      子宮形態異常
      甲状腺機能異常
      血栓性疾患
      染色体異常
      原因不明不育症

    各論 Q & A
      タイミング法・配偶者間人工受精による一般不妊治療
      子宮筋腫や子宮内膜症に対する手術とその後の妊娠率
      子宮筋腫・子宮腺筋症合併女性の妊娠後合併症
      子宮内膜症合併妊娠女性の妊娠後合併症
      子宮筋腫核出術後の患者の妊娠後合併症と発生率
      手術を要する子宮筋腫をもつ高齢女性
      卵巣子宮内膜症性嚢胞・子宮腺筋症をもつ不妊症に対する不妊治療
      多嚢胞性卵巣症候群(PCOS)
      早発卵巣不全(primary ovarian insufficiency;POI)を含む卵巣機能低下症例
      卵管機能障害
      原因不明不妊症
      反復着床不全症例
      男性不妊症
      無精子症症例
      潜在性甲状腺機能低下症
      血栓性疾患由来の不育症
      原因不明不育症
      胚(受精卵)・卵子・精子・卵巣組織凍結保存
      着床前診断と出生前診断
      第三者配偶子を用いた生殖医療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

総論 なぜ不妊症・不育症になるのか ?

P.8 掲載の参考文献
1) 厚生労働省 : 令和元年人口動態統計月報年計 (概数) の概況 : 結果の概要.
2) Templeman C : Adolescent endometriosis. Obstet Gynecol Clin North Am 2009 ; 36 : 177-85.
3) 吉田穂波, 加藤則子, 横山徹爾 : 人口動態統計からみた長期的な出生時体重の変化と要因について. 保健医療科学 2014 ; 63 : 2-16.
4) Ehrenberg HM, Dierker L, Milluzzi C, et al : Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes. Am J Obstet Gynecol 2003 ; 189 : 1726-30.
5) 厚生労働省 : 平成30年人口動態統計.
6) Osmond C, Barker DJ, Winter PD, et al : Early growth and death from cardiovascular disease in women. BMJ 1993 ; 307 : 1519.
7) 福岡秀興 : クリニカルカンファレンス 7 妊娠中の栄養管理と出生児の予後 2) 胎内低栄養環境と成人病素因の形成. 日産婦誌 2008 ; 60 : N 300-5.
P.16 掲載の参考文献
1) Johnson K, Posner SF, Biermann J, et al : Recommendations to improve preconception health and health care-United States. A report of the CDC/ATSDR Preconception Care World Group and the Select Panel on Preconception Care. MMWR Recomm Rep 2006 ; 55 : 1-23.
2) WHO : Preconception Care ; Maximizing the gains for maternal and child health. Policy brief. Geneva : WHO 2013.
3) Hanson MA, Bardsley A, De-Regil LM, et al : The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition : "Think Nutrition First". Int J Gynecol Obstet 2016 ; 131 Suppl 4 : S 213-53.
4) 荒田尚子 : プレコンセプションケアと産後フォローアップ ; 妊娠前後の母性内科の役割. 医学のあゆみ 2016 ; 256 : 199-205.
5) 吉田穂波ほか : 人口動態統計からみた長期的な出生時体重の変化と要因について. 保健医療科学 2014 ; 63 No. 1 : 2-16.
6) 福岡秀興 : 胎内低栄養環境と成人病素因の形成. 日産婦誌 2008 ; 60 : N- 300-N-305.
7) Stewart AF, et al : Fertility concerns for the aging male. Urology 2011 ; 78 : 496-9.
8) 佐藤雄一 : 不妊外来におけるプレコンセプションケア. 産と婦 2020 ; 87 : 927-35.
9) Stephenson J, Heslehurst N, Hall J, et al : Before the beginning : nutrition and lifestyle in the preconception period and its importance for future health. Lancet 2018 ; 391 : 1830-41.
P.22 掲載の参考文献
1) 厚生労働省 : 令和元年 (2019) 人口動態統計 (確定数) の概況. 2020.
2) Broekmans FJ, Soules MR, Fauser BC : Ovarian aging : mechanisms and clinical consequences. Endocr Rev 2009 ; 30 : 465-93.
3) vannoodzaadstra BM, Looman CWN, Alsbach H, et al : Delaying childbearing : effect of age on fecundity and outcome of pregnancy. BMJ 1991 ; 302 : 1361-5.
4) Faddy MJ, Gosden RG, Gougeon A, et al : Accelerated disappearance of ovarian follicles in midlife : implications for forecasting menopause. Hum Reprod 1992 ; 7 : 1342-6.
5) Seifer DB, Baker VL, Leader B : Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril 2011 ; 95 : 747-50.
6) Kelsey TW, Wright P, Nelson SM, et al : A validated model of serum anti-mullerian hormone from conception to menopause. PLos One 2011 ; 6 : e22024.
7) Carlsson IB, Scott JE, Visser JA, et al : Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 2006 ; 21 : 2223-7.
8) Durlinger AL, Gruijters MJ, Kramer P, et al : Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001 ; 142 : 4891-9.
9) Newberger DS : Down syndrome : prenatal risk assessment and diagnosis. Am Fam Physician 2000 ; 62 : 825-32.
10) Nybo Andersen AM, Wohlfahrt J, Christens P, et al : Maternal age and fetal loss : population based register linkage study. BMJ 2000 ; 320 : 1708-12.
11) Yeh JS, Steward RG, Dude AM, et al : Pregnancy outcomes decline in recipients over age 44 : an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology. Fertil Steri 2014 ; 101 : 1331-6.
P.26 掲載の参考文献
1) Faddy MJ, Gosden RG, Gougeon A, et al : Accelerated disappearance of ovarian follicles in mid-life : implications for forecasting menopause. Hum Reprod 1992 ; 7 : 1342-6.
2) Fenton AJ : Premature ovarian insufficiency : Pathogenesis and management. J Midlife Health 2015 ; 6 : 147-53.
3) Kuroda M, Kuroda K, Arakawa A, et al : Histological assessment of impact of ovarian endometrioma and laparoscopic cystectomy on ovarian reserve. J Obstet Gynaecol Res 2012 ; 38 : 1187-93.
4) Raffi F, Metwally M, Amer S : The impact of excision of ovarian endometrioma on ovarian reserve : a systematic review and meta-analysis. J Clin Endocrinol Metab 2012 ; 97 : 3146-54.
5) Ozaki R, Kumakiri J, Tinelli A, et al : Evaluation of factors predicting diminished ovarian reserve before and after laparoscopic cystectomy for ovarian endometriomas : a prospective cohort study. J Ovarian Res 2016 ; 9 : 37.
6) Iwase A, Nakamura T, Nakahara T, et al : Assessment of ovarian reserve using anti-Mullerian hormone levels in benign gynecologic conditions and surgical interventions : a systematic narrative review. Reprod Biol Endocrinol 2014 ; 12 : 125.
7) Lutchman Singh K, Davies M, Chatterjee R : Fertility in female cancer survivors : pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 2005 ; 11 : 69-89.
8) Levine J, Canada A, Stern CJ : Fertility preservation in adolescents and young adults with cancer. J Clin Oncol 2010 ; 28 : 4831-41.
9) Kuroda K, Ikemoto Y, Ochiai A, et al : Combination treatment of preoperative embryo cryopreservation and endoscopic surgery (surgery-ART hybrid therapy) in infertile women with diminished ovarian reserve and uterine myomas or ovarian endometriomas. J Minim Invasive Gynecol 2019 ; 26 : 1369-75.
P.31 掲載の参考文献
1) Kanasaki H, Bedecarrats GY, Kam KY, et al : Gonadotropin-releasing hormone pulse frequencydependent activation of extracellular signal-regulated kinase pathways in perifused LbetaT 2 cells. Endocrinology 2005 ; 146 : 5503-13.
2) Gougeon A : Regulation of ovarian follicular development in primates : facts and hypotheses. Endocr Rev 1996 ; 17 : 121-55.
3) Hillier SG, Whitelaw PF, Smyth CD : Follicular oestrogen synthesis : the 'two-cell, two-gonadotropin' model revisited. Mol Cell Endocrinol 1994 ; 100 : 51-4.
P.36 掲載の参考文献
1) Gellersen B, Brosens JJ : Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev 2014 ; 35 : 851-905.
2) 日本生殖医学会編 : 生殖医療の必修知識 2020. 日本生殖医学会, 2020, p 30-5.
3) Kawamura M, Ezawa M, Onodera T, et al : Frequency of rate of body temperature chart at mid cycle in pregnant women and the subsequent effect on pregnancy. Clin Exp Obstet Gynecol 2008 ; 35 : 45-7.
4) Direito A, Bailly S, Mariani A, et al : Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Fertil Steril 2013 ; 99 : 279-85.
P.44 掲載の参考文献
1) Gougeon A : Regulation of ovarian follicular development in primates : facts and hypotheses. Endocr Rev 1996 ; 17 : 121-55.
2) Miyazaki S, Shirakawa H, Nakada K, et al : Essential role of the inositol 1, 4, 5-trisphosphate receptor/Ca2+ release channel in Ca2+ waves and Ca2+ oscillations at fertilization of mammalian eggs. Dev Biol 1993 ; 158 : 62-78.
3) Kuroda K : Sperm factor, PLCζ, and egg Activation. J Mamm Ova Res 2010 ; 27 : 198-203.
4) Swann K, Ozil JP : Dynamics of the calcium signal that triggers mammalian egg activation. Int Rev Cytol. 1994 ; 152 : 183-222.
5) Gellersen B, Brosens JJ : Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev 2014 ; 35 : 851-905.
P.50 掲載の参考文献
1) Stevens VC : Some reproductive studies in the baboon. Hum Reprod Update 1997 ; 3 : 533-40.
2) Viudes-de-Castro MP, Vicente JS : Effect of sperm count on the fertility and prolificity rates of meat rabbits. Anim Reprod Sci 1997 ; 46 : 313-9.
3) Evers JLH : Female subfertility. Lancet 2002 ; 360 : 151-9.
4) Rowe PJ, Farley TM : The standardized investigation of the infertile couple. In : Rowe PJ, Vikhlaeva EM (eds) WHO Symposium on Diagnosis and Treatment of Infertility, Yerevan, Armenia Toronto : Hans Huber Publisher, 1988 ; 15-41.
5) Shibahara H, Tsunoda T, Taneichi A, et al : Diversity of antisperm antibodies bound to sperm surface in male immunological infertility. Am J Reprod Immunol 2002 ; 47 : 146-50.
6) Witkin SS, Viti D, David SS, et al : relation between antisperm antibodies and the rate of fertilization of human oocytes invitro. J Assist Reprod Genet 1992 ; 9 : 9-13.
7) Nakagawa K, Kwak-Kim J, Ota K, et al : Immunosuppression with Tacrolimus Improved Reproductive Outcome of Women with Repeated Implantation Failure and Elevated Peripheral Blood Th 1/Th 2 Cell Ratios. A J Reprod Immunol 2015 ; 73 : 353-61.
P.55 掲載の参考文献
1) Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility : Optimizing natural fertility : a committee opinion. Fertil Steril 2013 ; 100 : 631-7.
2) van Weert JM, Sjoerd Repping M.Sc, Van Voorhis, et al : Performance of the postwash total motile sperm count as a predictor of pregnancy at the time of intrauterine insemination : A meta-analysis. Fertil Steril 2004 ; 82 : 612-20.
3) Huang HY, Lee CL, Lai YM, et al : The impact of the total motile sperm count on the success of intrauterine insemination with husband's spermatozoa. J Assist Reprod Genet 1996 ; 13 : 56-63.
4) Coppus SF, Land JA, Opmeer BC, et al : Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology. Hum Reprod 2011 ; 26 : 3061-7.
5) Johnson N, van Voorst S, Sowter MC, et al : Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2010 ; (1) : CD 002125.
6) Kobayashi S, Bessho T, Shigeta M, et al : Correlation between quantitative antibody titers of sperm immobilizing antibodies and pregnancy rates by treatments. Fertil Steril 1990 ; 54 : 1107-13.
7) Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons : Myomas and reproductive function. Fertil Steril 2008 ; 90 : S 125-30.
8) Legendre G, Catala L, Moriniere C, et al : Relationship between ovarian cysts and infertility : What surgery and when? Fertil Steril 2014 ; 101 : 608-14.
9) Vloeberghs V, Verheyen G, Haentjens P, et al : How successful is TESE-ICSI in couples with nonobstructive azoospermia? Hum Reprod 2015 ; 30 : 1790-6.
10) Gunn DD, Bates GW : Evidence-based approach to unexplained infertility : a systematic review. Fertil Steril 2016 ; 105 : 1566-74.
11) Good Clinical treatment in Assisted Reproduction. -An ESHRE position paper. European Society of Human Reproduction and Embryology (ESHRE), 2009, 1-5.
12) National Collaborating Centre for Women's and Children's Health (UK) : Fertility : Assessment and Treatment for People with Fertility Problems. National Institute for Health and Clinical Excellence : Guidance. 2013.
13) Goldman MB, Thornton KL, Ryley D, et al : A randomized clinical trial to determine optimal infertility treatment in older couples : The Forty and over Treatment Trial (FORT-T). Fertil Steril 2014 ; 101 : 1574-81.
P.61 掲載の参考文献
1) Levine H, Jorgensen N, Martino-Andrade A, et al : Temporal trends in sperm count : a systematic review and meta-regression analysis. Hum Reprod Update 2017 ; 23 : 646-59.
2) Tsujimura A, Hiramatsu I, Nagashima Y, et al : Erectile dysfunction is predictive symptom for poor semen in newlywed men in Japan. Sex Med 2020 ; 8 : 21-9.
3) Levitas E, Lunenfeld E, Weisz N, et al : Relationship between age and semen parameters in men with normal sperm concentration : analysis of 6022 semen samples. Andrologia 2007 ; 39 : 45-50.
4) Zhao L, Pang A : Effects of metabolic syndrome on semen quality and circulating sex hormones : A systematic review and meta-analysis. Front Endocrinol 2020 ; 11 : 428.
5) Sharma R, Harlev A, Agarwal A, et al : Cigarette Smoking and Semen Quality : A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen. Eur Urol 2016 ; 70 : 635-45.
6) Goldstein M, Eid JF : Elevation of intratesticular and scrotal skin surface temperature in men with varicocele. J Urol 1989 ; 142 : 743-5.
7) Tsujimura A : Microdissection testicular sperm extraction : prediction, outcome, and complications. Int J Urol 2007 ; 10 : 883-9.
8) Minhas S, Bettocchi C, Boeri L, et al, EAU Working Group on Male Sexual and Reproductive Health : European Association of Urology Guidelines on Male Sexual and Reproductive Health : 2021 Update on Male Infertility. Eur Urol Epub 2021 ; 80 (5) : 603-20.
9) Belva F, Bonduelle M, Roelants M, et al : Semen quality of young adult ICSI offspring : the first results. Hum Reprod 2016 ; 31 : 2811-20.
P.66 掲載の参考文献
1) 日本産科婦人科学会/日本産婦人科医会編 : 産婦人科診療ガイドライン-産科編 2020, 日本産科婦人科学会, 2020.
2) Nybo Andersen AM, Wohlfahrt J, Christens P, et al : Maternal age and fetal loss : population based register linkage study. BMJ 2000 ; 320 : 1708-12.
3) Larsen EC, Christiansen OB, Kolte AM, et al : New insights into mechanisms behind miscarriage. BMC Med 2013 ; 11 : 154.
4) Ogasawara M, Aoki K, Okada S, et al : Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000 ; 73 : 300-4.
5) Cacciatore B, Tiitinen A, Stenman UH, et al : Normal early pregnancy : serum hCG levels and vaginal ultrasonography findings. Br J Obstet Gynaecol 1990 ; 97 : 899-903.
6) Liu KE, Hartman M, Hartman A, et al : The impact of a thin endometrial lining on fresh and frozen-thaw IVF outcomes : an analysis of over 40000 embryo transfers. Hum Reprod 2018 ; 33 : 1883-8.
7) Baradwan S, Shafi D, Baradwan A, et al : The effect of endometrial thickness on pregnancy outcome in patients with Asherman's syndrome post-hysteroscopic adhesiolysis. Int J Women's Health 2018 ; 10 : 77-82.
8) Mouhayar Y, Franasiak JM, Sharara FI : Obstetrical complications of thin endometrium in assisted reproductive technologies : a systematic review. J Assist Reprod Genet 2019 ; 36 : 607-11.
9) Lucas ES, Dyer NP, Murakami K, et al : Loss of Endometrial Plasticity in Recurrent Pregnancy Loss. Stem Cells 2016 ; 34 : 346-56.
10) Murakami K, Bhandari H, Lucas ES, et al : Deficiency in clonogenic endometrial mesenchymal stem cells in obese women with reproductive failure-a pilot study. PLoS One 2013 ; 8 : e82582.
P.72 掲載の参考文献
1) Teklenburg G, Salker M, Heijnen C, et al : The molecular basis of recurrent pregnancy loss : impaired natural embryo selection. Mol Hum Reprod 2010 ; 16 : 886-95.
2) Sugiura-Ogasawara M, Suzuki S, Ozaki Y, et al : Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness : the Okazaki Cohort Study in Japan. J Obstet Gynaecol Res 2013 ; 39 : 126-31.
3) Ota K, Dambaeva S, Han AR, et al : Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Hum Reprod 2014 ; 29 : 208-19.
4) Ikemoto Y, Kuroda K, Nakagawa K, et al : Vitamin D Regulates Maternal T-Helper Cytokine Production in Infertile Women. Nutrients 2018 ; 10 : 902.
5) Wang LQ, Yan XT, Yan CF, et al : Women with Recurrent Miscarriage Have Decreased Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase by the Fetal-Maternal Interface. PLoS One 2016 ; 11 : e0165589.
6) Franssen MTM, Korevaar JC, van der Veen F, et al : Reproductive outcome after chromosome analysis in couples with two or more miscarriages : index [corrected] -control study. BMJ 2006 ; 332 : 759-63.
7) Morita K, Ono Y, Takeshita T, et al : Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan. J Obstet Gynaecol Res 2019 ; 45 : 1997-2006.
8) Evers JLH : Female subfertility. Lancet 2002 ; 360 : 151-9.
9) Tietze C, Guttmacher AF, Rubin S : Time required for conception in 1727 planned pregnancies. Fertil Steril 1950 ; 1 : 338-46.
10) Salker M, Teklenburg G, Molokhia M, et al : Natural selection of human embryos : impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One 2010 ; 5 : e10287.
P.78 掲載の参考文献
1) 佐田文宏, 山田秀人 : 厚生労働省科学研究費補助金 (成育疾患克服等次世代育成基盤研究事業) 不育症に係わる遺伝要因, 環境要因およびそれらの交互作用. 2011.
2) Maconochie N, Doyle P, Prior S, et al : Risk factors for first trimester miscarriage-results from a UK-population-based case-control study. BJOG 2007 ; 114 : 170-86.
3) Peacock JL, Bland JM, Anderson HR : Preterm delivery-effects of socioeconomicfactors, psychological stress, smoking, alcohol, and caffeine. BMJ 1995 ; 311 : 531-5.
4) Sugiura-Ogasawara M, Ozaki Y, Suzumori N : Management of recurrent miscarriage. J Obstet Gynecol Res 2014 ; 40 : 1174-9.
5) 山本樹生, 千島史尚, 市川剛ほか : 抗リン脂質抗体症候群. 産と婦 2016 ; 83 : 521-7.
6) 日本産科婦人科学会/日本産婦人科医会. CQ004-1 妊娠中の深部静脈血栓症 (DVT) の予防法は? 産婦人科診療ガイドライン-産科編 2020 : 8-12.
7) 中山敏男, 永松健 : 不育症の検索手順. 臨婦産 不妊・不育症診療パーフェクトガイド 2016 ; 70 : 314-9.
8) 伊熊慎一郎, 田中威づみ, 山口貴史ほか : 染色体異常. 産と婦 2016 ; 83 : 485-90.
9) Ikuma S, Sato T, Sugiura-Ogasawara M, et al : Preimplantation genetic diagnosis and natural conception : a comparison of live birth rates in patients with recurrent pregnancy loss associated with translocation. PLoS One 2015 ; 10 : e0129958.
10) Nybo Andersen AN, Wohlfahrt J, Christens P, et al : Maternal age and fetal loss : population based register linkage study. BMJ 2000 ; 320 : 1708-12.
11) Morita K, Ono Y, Takeshita T, et al : Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan. J Obstet Gynaecol Res 2019 ; 45 : 1997-2006.
12) Gellersen B, Brosens JJ : Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev 2014 ; 35 : 851-905.
13) Weimar CH, Kavelaars A, Brosens JJ, et al : Endometrial stromal cells of women with recurrent miscarriage fail to discriminate between high-and low-quality human embryos. Plos One 2012 ; 7 : e41424.
14) Coomarasamy A, Williams H, Truchanowicz E, et al : A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med 2015 ; 373 : 2141-8
15) Coomarasamy A, Devall AJ, Brosens JJ, et al : Micronized vaginal progesterone to prevent miscarriage : a critical evaluation of randomized evidence. Am J Obstet Gynecol 2020 ; 223 : 167-76.

総論 Q & A

P.87 掲載の参考文献
1) 厚生労働省 : 平成26年 国民健康・栄養調査結果の概要.
2) Provost MP, Acharya KS, Acharya CR, et al : Pregnancy outcomes decline with increasing body mass index : analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. Fertil Steril 2016 ; 105 : 663-9.
3) Petersen GL, Schmidt L, Pinborg A, et al : The influence of female and male body mass index on live births after assisted reproductive technology treatment : a nationwide register-based cohort study. Fertil Steril 2013 ; 99 : 1654-62.
4) Rich-Edwards JW, Spiegelman D, Garland M, et al : Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology 2002 ; 13 : 184-90.
5) 厚生労働省 : 妊産婦のための食生活指針-「健やか親子21」推進検討報告書-平成18年.
6) 厚生労働省・農林水産省 : フードガイド検討会報告書. 食事バランスガイド. 2005.
7) Chavarro JE, Willett W, Skerrett P : The Fertility Diet : Groundbreaking Research Reveals Natural Ways to Boost Ovulation & Improve Your Chances of Getting Pregnant. McGraw-Hill Contemporary, 2009.
8) Chavarro JE, Rich-Edwards JW, Rosner BA, et al : Use of multivitamins, intake of B vitamins, and risk of ovulatory infertility. Fertil Steril 2008 ; 89 (3) : 668-76.
9) Chavarro JE, Rich-Edwards JW, Rosner BA, et al : Iron intake and risk of ovulatory infertility. Obstet Gynecol 2006 ; 108 : 1145-52.
10) Gudmundsdottir SL, Flanders WD, Augestad LB : Physical activity and fertility in women : the North-Trondelag Health Study. Hum Reprod 2009 ; 24 : 3196-204.
11) Lauren AWise, Kenneth JR, Ellen MM, et al : A prospective cohort study of physical activity and time to pregnancy. Fertil Steril 2012 ; 97 : 1136-42.
12) Hsiao W, Shrewsberry AB, Moses KA, et al : Exercise is associated with better erectile function in men under 40 as evaluated by the International Index of Erectile Function. J Sex Med 2012 ; 9 : 524-30.
P.97 掲載の参考文献
1) Matsuda Y, Kawamichi Y, Hayashi K, et al : Impact of maternal age on the incidence of obstetrical complications in Japan. J Obstet Gynecol Res 2011 ; 37 : 1409-14.
2) Cleary-Goldman J, Malone FD, Vidaver J, et al : Impact of maternal age on obstetric outcome. Obstet Gynecol 2005 ; 105 : 983-90.
3) Nybo Anderson AM, Wohlfahrt J, Christens P, et al : Maternal age and fetal population based resister linkage study. BMJ 2000 ; 320 : 1708-12.
4) Maternal Fetal Medicine : Practice and Principles. third ed. Creasy RK, Resnick R, eds. WB Saunders, 1994, p 71.
5) The Fetal Medicine Foundation. Available from URL : (https://courses.fetalmedicine.com/fmf/introduction?locale=en)
6) Osamu Samura : Update on noninvasive prenatal testing : A review based on currentworldwide research. J Obstet Gynaecol Res 2020 ; 46 : 1246-54, PMID : 32558079.
7) Practice Bulletin No. 162 : Prenatal Diagnostic Testing for Genetic Disorders. Obstet Gynecol 2016 ; 127 : e108-e 122.
P.106 掲載の参考文献
1) Coronado GD, Marshall LM, Schwartz SM : Complications in pregnancy, labor, and delivery with uterine leiomyomas : a population-based study. Obstet Gynecol 2000 ; 95 : 764-9.
2) 平松祐司編 : 子宮筋腫合併妊婦の管理. 子宮筋腫の臨床 第1版, メジカルビュー社, 2008, 227-34.
3) Exacoustos C, Rosati P : Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 1993 ; 82 : 97-191.
4) 村田雄二編 : 合併症妊娠 改訂2版, メディカ出版, 2003, 34.
5) 東正弘 : II クリニカルカンファランス B.妊娠合併症の取り扱い 3. 卵巣腫瘍. 日産婦誌 1995 ; 47 : N 197-200.
6) 青木陽一 : クリニカルカンファランス 5. 婦人科腫瘍合併妊婦の取り扱い 3. 卵巣腫瘍 日産婦誌 2007 ; 59 : N 556-9.
7) 下平和久, 岡井崇 : 子宮・卵巣腫瘍合併妊娠の問題点とその対策 合併症妊娠とその管理. 産婦治療 2006 ; 93 : 201-7.
8) Donegan WL : Cancer and pregnancy. CA Cancer J Clin 1983 ; 33 : 194-214.
9) Shivvers SA : Preinvasive and invasive breast and cervical cancer prior to or during pregnancy. Clin Perinatol 1997 ; 24 : 369-89.
10) Sadler L, Saftlas A, Wang W, et al : Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004 ; 291 (17) : 2100-6.
11) 松浦裕行, 佐地勉 : 系統別疾患のキャリーオーバー 循環器疾患. 治療 2003 ; 85 : 26-30.
12) Clark SL : Labor and delivery in the patient with structural cardiac disease. Clin Perinatol 1986 ; 13 : 695.
13) The Seventh Report of the Joint National Committee. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health National Heart, Lung, and Blood Institute, 2004.
14) Vasan RS, Larson MG, Leip EP, et al : Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study : a cohort study. Lancet 2001 ; 358 : 1682-6.
15) Makino S, Iwata A, Seki H, et al : Pre-hypertension predicts pregnancy induced hypertension and its postpartum progress. Hypertens Res in pregnancy 2013 ; 1 : 71-4.
16) 牧野真太郎, 竹田省 : 周産期臨床検査のポイント 基本的な検査 妊娠時の心肺機能. 周産期医学 2008 ; 38 : 27-30.
17) 日本高血圧学会高血圧治療ガイドライン作成委員会 編 : 高血圧治療ガイドライン 2019. ライフサイエンス出版, 2019.
18) Namazy JA, Schatz M : Pregnancy and asthma : Recent developments. Curr Opin Pulm Med 2005 ; 11 : 56-60.
19) Schatz M, Dombrowski MP, Wise R, et al : Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol 2003 ; 112 : 283-8.
20) Tan KS, Thomson NC : Asthma in pregnancy. Am J Med 2000 ; 109 : 727-33.
21) American College of Obstetricians : Asthma in pregnancy. ACOG Practice Bulletin No. 90. Obstet Gynecol 2008 ; 111 : 457-64.
22) 田所望, 稲葉憲之 : 周産期診療プラクティス 5. 呼吸器疾患合併妊娠. 産婦治療 2008 ; 96 : 637-41.
23) 大楽紀子, 小島康弘, 樋渡信夫 : クローン病診療の進歩 妊娠と活動期の関係. Modern Physician 2007 ; 27 : 978-80.
24) Fonager K, Sorensen HT, Olsen J, et al : Pregnancy outocome for women with Crohn's disease : a follow-up study based on linkage between national registries. Am J Gastroenterol 1998 ; 93 : 2426-30.
25) Dominitz J, Young JC, Boyko EJ : Outcomes of infants born to mothers with inflammatory bowel disease : a population-based cohort study. Am J Gastroenterol 2002 ; 97 : 641-8.
26) 高添正和, 酒匂美奈子 : 炎症性腸疾患と妊娠出産. Medical Practice 2005 ; 22 : 787-92.
27) 酒匂美奈子, 高添正和 : クローン病診療の進歩 薬物療法との関係. Medical Practice 2007 ; 22 : 981-3.
28) 吉田幸洋 : クリニカルカンファランス 3) 内科疾患合併妊娠の管理 (1) 膠原病. 日産婦誌 2000 ; 52 : N 258-62.
29) Makino S, Yonemoto H, Itoh S, et al : Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjogren's syndrome. Acta Obstet Gynecol Scand 2007 ; 86 : 1145-6.
30) Buyon JP : Autoantibodies reactive with Ro (SSA) and La (SSB) and pregnancy. J Rheumatol suppl 1997 ; 24 : 12-6.
31) Otani K : Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn 1985 ; 39 : 33-41.
32) 日本産科婦人科学会/日本産婦人科医会編 : 産婦人科診療ガイドライン 産科編 2020. 日本産科婦人科学会, 東京, 2020.
33) 兼子直, 管るみ子, 田中正樹ほか : てんかんをもつ妊娠可能年齢の女性に対する治療ガイドライン. てんかん研究 2007 ; 25 : 27-31.
P.114 掲載の参考文献
1) Segawa T, Kuroda T, Kato K, et al : Cytogenetic analysis of the retained products of conception after missed abortion following blastocyst transfer : a retrospective, large-scale, single-centre study. Reprod Biomed Online 2017 ; 34 : 203-10.
2) 西山幸江, 西澤春紀, 大江瑞恵ほか : 産婦人科臨床で扱われる染色体異常. 産婦の実際 2011 ; 60 : 1277-85.
3) Sugiura-Ogasawara M, Aoki K, Fujii T, et al : Subsequent pregnancy outcomes in recurrent miscarriage patients with a paternal or maternal carrier of structural chromosome rearrangement. J Hum Genet 2008 ; 53 : 622-8.
4) Ogasawara M, Aoki K, Okada S, et al : Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000 ; 73 : 300-4.
5) 小澤伸宏 : 不育と染色体異常. 産婦の実際 2015 ; 64 : 349-54.
6) Franssen MT, Korevaar JC, van der Veen F, et al : Reproductive outcome after chromosome analysis in couples with two or more miscarriages : index [corrected] -control study. BMJ 2006 ; 332 : 759-63.
7) Ikuma S, Sato T, Sugiura-Ogasawara M, et al : Preimplantation genetic diagnosis and natural conception : a comparison of live birth rates in patients with recurrent pregnancy loss associated with translocation. PLoS One 2015 ; 10 : e0129958.
8) Sato T, Sugiura-Ogasawara M, Ozawa F, et al : Preimplantation genetic testing for aneuploidy : a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure. Hum Reprod 2019 ; 34 : 2340-8.
9) Bhatt SJ, Marchetto NM, Roy J, et al : Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL) : a SART-CORS study. Hum Reprod 2021 ; 36 : 2339-44.

各論1 不妊治療の実際 - どのように妊娠に導くのか ?

P.120 掲載の参考文献
1) El-Toukhy T, Campo R, Sunkara SK, et al : A multi-centre randomised controlled study of pre-IVF outpatient hysteroscopy in women with recurrent IVF implantation failure : Trial of Outpatient Hysteroscopy-[TROPHY] in IVF. Reprod Health 2009 ; 6 : 20.
2) Smit JG, Kasius JC, Eijkemans MJC, et al : Hysteroscopy before in-vitro fertilisation (inSIGHT) : a multicentre, randomised controlled trial. Lancet 2016 ; 387 : 2622-9.
3) El-Toukhy T, Campo R, Khalaf Y, et al : Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY) : a multicentre, randomised controlled trial. Lancet 2016 ; 387 : 2614-21.
4) Johnston-MacAnanny EB, Hartnett J, Engmann LL, et al : Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril 2010 ; 93 : 437-41.
P.129 掲載の参考文献
1) Wilcox AJ, Weinberg CR, Baird DD : Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med. 1995 ; 333 : 1517-21.
2) Andersen AG, Als-Nielsen B, Hornnes PJ, et al : Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod 1995 ; 10 : 3202-5.
3) Hafez ES : In vivo and in vitro sperm penetration in cervical mucus. Acta Eur Fertil 1979 ; 10 : 41-9.
4) Behre HM, Kuhlage J, Gassner C, et al : Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor : comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 2000 ; 15 : 2478-82.
5) Hernandez J, Rodriguez-Fuentes A, Puopolo M, et al : Follicular Volume Predicts Oocyte Maturity : A Prospective Cohort Study Using Three-Dimensional Ultrasound and SonoAVC. Reprod Sci 2016 ; 23 : 1639-43.
6) Palatnik A, Strawn E, Szabo A, et al : What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles. Fertil Steril 2012 ; 97 : 1089-94. e1-3.
7) Kawachiya S, Matsumoto T, Bodri D, et al : Short-term, low-dose, non-steroidal anti-inflammatory drug application diminishes premature ovulation in natural-cycle IVF. Reprod Biomed Online 2012 ; 24 : 308-13.
P.135 掲載の参考文献
1) 日本乳癌学会編 : 乳癌診療ガイドライン 1 治療編 2018年版. 金原出版 (東京), 2018.
2) Zarei A, Sohail P, Parsanezhad ME, et al : Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles : a randomized clinical trial. Arch Gynecol Obstet 2017 ; 295 : 239-46.
P.141 掲載の参考文献
1) Mourad S, Brown J, Farquhar C : Interventions for the prevention of OHSS in ART cycles : an overview of Cochrane reviews. The Cochrane database of systematic reviews 2017 ; 1 : Cd 012103.
2) Miles RA, Paulson RJ, Lobo RA, et al : Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes : a comparative study. Fertil Steril 1994 ; 62 : 485-90.
3) Mohammed A, Woad KJ, Mann GE, et al : Evaluation of progestogen supplementation for luteal phase support in fresh in vitro fertilization cycles. Fertil Steril 2019 ; 112 : 491-502.e3.
4) Schindler AE, Campagnoli C, Druckmann R, et al : Classification and pharmacology of progestins. Maturitas 2008 ; 61 : 171-80.
5) Practice Committee of the American Society for Reproductive Medicine : Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility : an educational bulletin. Fertil Steril 2008 ; 89 : 789-92.
6) Kuroda K, Venkatakrishnan R, Salker MS, et al : Induction of 11 beta-HSD 1 and Activation of Distinct Mineralocorticoid Receptor- and Glucocorticoid Receptor-Dependent Gene Networks in Decidualizing Human Endometrial Stromal Cells. Mol Endocrinol 2013 ; 27 : 192-202.
7) Kuang Y, Chen Q, Fu Y, et al : Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2015 ; 104 : 62-70.e3.
P.147 掲載の参考文献
1) Palatnik A, Strawn E, Szabo A, et al : What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles. Fertil Steril 2012 ; 97 : 1089-94.
2) Fauque P, Lehert P, Lamotte M, et al : Clinical success of intrauterine insemination cycles is affected by the sperm preparation time. Fertil Steril 2014 ; 101 : 1618-23.
3) Cooper TG, Noonan E, von Eckardstein S, et al : World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010 ; 16 : 231-45.
4) Wilcox AJ, Weinberg CR, Baird DD : Post-ovulatory ageing of the human oocyte and embryo failure. Hum Reprod 1998 ; 13 : 394-7.
5) Wilcox AJ, Weinberg CR, Baird DD : Timing of sexual intercourse in relation to ovulation-Effects on the Probability of Conception, Survival of the Pregnancy, and Sex of the Baby. N Engl J Med 1995 ; 333 : 1517-21.
6) Allahbadia NG : Does The Time Interval Between Semen Collection, Processing & Insemination affect results of IUI?. J obstet Gynecol India 2009 ; 59 : 407-9.
7) 柴原浩章 : 症例から学ぶ生殖医学 不妊 抗精子抗体. 日産婦誌 2005 ; 57 : 325-31.
P.153 掲載の参考文献
1) Steiner AZ, Jukic AM : Impact of female age and null gravidity on fecundity in an older reproductive age cohort. Fertil Steril 2016 ; 105 : 1584-8.
2) Evers JL : Female subfertility. Lancet 2002 ; 360 : 151-9.
3) 大野原良晶ほか : 当院不妊外来における治療成績と年齢との関連. 鳥取医誌 2012 ; 40 : 130-5.
4) Honda T, Tsutsumi M, Komoda F, et al : Acceptable pregnancy rate of unstimulated intrauterine insemination : a retrospective analysis of 17, 830 cycles. Reprod Med Biol 2015 ; 14 : 27-32.
5) 日本産科婦人科学会 : ARTデータブック 2018.
P.160 掲載の参考文献
1) 京野廣一 : 排卵誘発-誘発派. 産婦の実際 2009 ; 58 : 1806.
2) 高橋克彦 : GnRH アンタゴニストの効果的応用. 今日の不妊診療, 医歯薬出版株式会社, 2004, 195.
3) Tobler KJ, Zhao Y, Weissman A, et al : Worldwide survey of IVF practices : trigger, retrieval and embryo transfer techniques. Arch Gynecol Obstet 2014 ; 290 : 561-8.
4) 中尾佳月, 高見澤聡ほか : 採卵決定日にLHサージが開始された採卵周期におけるレルゴリクスの排卵抑制効果. 日本IVF学会誌 2020 ; 23 : 24-6.
5) Kuang Y, Chen Q, Fu Y, et al : Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2015 ; 104 : 62-70.e3.
6) Nargund G, Datta AK, Fauser B : Mild stimulation for in vitro fertilization. Fertil Steril 2017 ; 108 : 558-67.
7) Fauser BC, Devroey P, Yen SS, et al : Minimal ovarian stimulation for IVF : appraisal of potential benefits and drawbacks. Hum Reprod 1999 ; 14 : 2681-6.
8) Rinaldi L, Lisi F, Selman H : Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome. J Endocrinol Invest 2014 ; 37 : 65-70.
9) Eftekhar M, Mohammadian F, Davar R, et al : Comparison of pregnancy outcome after letrozole versus clomiphene treatment for mild ovarian stimulation protocol in poor responders. Iran J Reprod Med 2014 ; 12 : 725-30.
10) Haas J, Casper RF : In vitro fertilization treatments with the use of clomiphene citrate or letrozole. Fertil Steril 2017 ; 108 : 568-71.
11) Teramoto S, Kato O : Minimal ovarian stimulation with clomiphene citrate : a large-scale retrospective study. Reprod Biomed Online 2007 ; 15 : 134-48.
12) Kuroda K, Kitade M, Kumakiri J, et al : A Minimum Ovarian Stimulation Involving Combined Clomiphene Citrate and Estradiol Treatment for In Vitro Fertilization of Bologna-Criteria Poor Ovarian Responders. J Obstet Gynaecol Res 2016 ; 42 : 178-83.
13) Ishii R, Tachibana N, Okawa R, et al : Different anti-Mulerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART) : Clues to better ART outcomes. Reprod Med Biol 2019 ; 18 : 263-72.
14) Sunkara SK, Rittenberg V, Raine-Fenning N, et al : Association between the number of eggs and live birth in IVF treatment : an analysis of 400135 treatment cycles. Hum Reprod 2011 ; 26 : 1768-74.
15) Sunkara SK, La Marca A, Seed PT, et al : Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF : an analysis of 65868 singleton live birth outcomes. Hum Reprod 2015 ; 30 : 1473-80.
16) Sahin N,Apaydin N, Toz E, et al : Comparison of the effects letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome. Arch Gynecol Obstet 2016 ; 293 : 1101-6.
P.164 掲載の参考文献
1) Knight DC, Tyler JP, Driscoll GL : Follicular flushing at oocyte retrieval : areappraisal. Aust N Z J Obstet Gynaecol 2001 ; 41 : 210-3.
2) Kara M, Aydin T, Turktekin N : Is follicular flushing really effective? A clinical study. Arch Gynecol Obstet 2012 ; 286 : 1061-4.
3) Mehri S, Levi Setti PE, Greco K, et al : Correlation between follicular diameters and flushing versus no flushing on oocyte maturity, fertilization rate and embryo quality. J Assist Reprod Genet 2014 ; 31 : 73-7.
P.170 掲載の参考文献
1) Hashimoto S, Nakano T, Yamagata K, et al : Multinucleation per se is not always sufficient as a marker of abnormality to decide against transferring human embryos, Fertil Steril 2016 ; 106 (1) : 133-9.
2) 日本哺乳動物卵子学会編 : 生命の誕生に向けて <第二版> 生殖補助医療 (ART) 胚培養の理論と実際. 近代出版, 東京, 2011.
3) Gardner DK, Lane M, Calderon I, et al : Environment of the preimplantation human embryo in vivo : metabolite analysis of oviduct and uterine fluids and metabolism of cumulus cells. Fertil Steril 1996 ; 65 : 349-53.
4) Fischer B 1, Bavister BD : Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil 1993 ; 99 : 673-9.
5) Ando H, Kobayashi M, Toda S, et al : Establishment of a ciliated epithelial cell line from human Fallopian tube. Hum Reprod 2000 ; 15 : 1597-603.
6) Duszewska AM, Reklewski Z, Pienkowski M, et al : Development of bovine embryos on Vero/BRL cell monolayers (mixed co-culture). Theriogenology 2000 ; 54 : 1239-47.
7) Trounson AO, Mohr LR, Wood C, et al : Effect of delayed insemination on in-vitro fertilization, culture and transfer of human embryos. J Reprod Fertil 1982 ; 64 : 285-94.
8) 中潟直己, 田中温 : 排卵直前のマウス卵胞卵の受精能および初期発生能に及ぼす卵子前培養の効果について. 日不妊会誌 1988 ; 33 : 160-5.
9) 中潟直己, 田中温 : 排卵直前マウス卵胞卵の新生仔への発生能に及ぼす卵子前培養の効果について. 日不妊会誌 1988 ; 33 : 415-8.
10) Edwards LJ, Williams DA, Gardner DK : Intracellular pH of the preimplantation mouse embryo : Effects of extracellular pH and weak acids, Molecular Reproduction and Development 1998 ; 50 : 434-42.
11) Alhelou Y, et al : Embryo culture conditions are significantly improved during uninterrupted incubation : a randomized controlled trial. Reprod Biol 2018 ; 18 : 40-5.
12) Cruz, et al : Embryo quality, blastocyst and ongoing pregnancy rates in oocyte donation patients whose embryos were monitored by time-lapse imaging. J Assist Reprod Genet 2011 ; 28 (7) : 569-73.
13) Zhan Q, et al : Direct Unequal Cleavages : Embryo Developmental Competence, Genetic Constitution and Clinical Outcome. Published online 2016.
14) Liu Y, et al : Prevalence, consequence, and significance of reverse cleavage by human embryos viewed with the use of the Embryoscope time-lapse video system. Fertil Steril 2014 ; 10 : 1295-300.
15) Basile N, et al : The use of morphokinetics as a predictor of implantation : a multicentric study to define and validate an algorithm for embryo selection. Hum Reprod 2015 ; 30 (2) : 276-83.
P.180 掲載の参考文献
1) Palermo G, Joris H, Devroey P, et al : Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992 ; 340 : 17-8.
2) 田中温, 田中威づみ, 永吉基 : 老化卵子救済のための卵細胞質置換 (今月の臨床 生殖医療の進歩と課題 : 安全性の検証から革新的知見まで) - (ARTの発展). 臨婦産 2014 ; 68 : 49-53.
3) JISART 編 : 結果の出せる不妊治療. メジカルビュー社, 2011.
4) Nagy ZP, et al : Fertilization and early embryology : Intracytoplasmic single sperm injection of 1-day-old unfertilized human oocytes. Hum Reprod 1993 ; 8 : 2180-4.
5) Chen C, et al : Rescue ICSI of oocytes that failed to extrude the second polar body 6 h postinsemination in conventional IVF. Hum Reprod 2003 ; 18 : 2118-21.
6) 山本新吾ほか : Conventional IVF周期におけるrescue ICSIを用いた受精障害回避の取り組み. 第33回日本受精着床学会, 2015, p 125.
7) 越知正憲ほか : レスキューICSIを中心とした当クリニックの対応. 第33回日本受精着床学会, 2015, p 126.
8) Tanaka A, et al : Direct visualization of metaphase-ii chromosomes in human oocytes under an inverted microscope. Recent Patents on Medical Imaging 2011 ; 1 : 84-8.
9) 見尾保幸 : Time-lapse cinematographyによるヒト初期胚発生過程の動的解析. 日産婦誌 60 ; 9 : 389-98.
P.186 掲載の参考文献
1) Kimura Y, Yanagimachi R : Intracytoplasmic sperm injection in the mouse. Biol Reprod 1995 ; 52 : 709-20.
2) Yanagida K, Katayose H, Yazawa H, et al : The usefulness of a piezomicromanipulator in intracytoplasmic sperm injection in humans. Hum Reprod 1999 ; 14 : 448-53.
3) Hiraoka K, Kitamura S : Clinical efficiency of Piezo-ICSI using micropipettes with a wall thickness of 0. 625μm. J Assist Reprod Genet 2015 ; 32 : 1827-33.
4) Rubino P, Vigano P, Luddi A, et al : The ICSI procedure from past to future : a systematic review of the more controvercial aspects. Hum Reprod Update 2016 ; 22 : 194-227.
5) Takeuchi S, Minoura H, Shibahara T, et al : Comparison of Piezo ‐ assisted micromanipulation with conventional micromanipulation for intracytoplasmic sperm injection into human oocytes. Gynecol Obstet Invest 2001 ; 52 : 158-62.
6) Furuhashi K, Saeki Y, Enatsu N, et al : Piezo-assisted ICSI improves fertilization and blastocyst development rates compared with conventional ICSI in women aged more than 35 years. Reprod Med Biol 2019 ; 18 : 357-61.
7) Fujii Y, Endo Y, Mitsuhata S, et al : Evaluation of the effect of piezo-intracytoplasmic sperm injection on the laboratory, clinical, and neonatal outcomes. Reprod Med Biol 2020 ; 19 : 198-205.
8) Deirdre ZF, Kevin L, Leanne PI, et al : PIEZO-ICSI increases fertilization rates compared with standard ICSI : a prospective cohort study. Reprod Biomed Online 2021 ; 43 : 404-12.
P.192 掲載の参考文献
3) The Eshre Guideline Groupon R.P.L., Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline : recurrent pregnancy loss. Hum Reprod Open 2018 ; 2018 : hoy 004-hoy.
4) Tavaniotou A, Smitz J, Bourgain C, et al. Ovulation induction disrupts luteal phase function. Ann N Y Acad Sci 2001 ; 943 : 55-63.
5) Beckers NG, Macklon NS, Eijkemans MJ, et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003 ; 88 : 4186-92.
6) Bjuresten K, Landgren BM, Hovatta O, et al. Luteal phase progesterone increases live birth rate after frozen embryo transfer. Fertil Steril 2011 ; 95 : 534-7.
7) Teklenburg G, Salker M, Heijnen C, et al. The molecular basis of recurrent pregnancy loss : impaired natural embryo selection. Mol Hum Reprod 2010 ; 16 : 886-95.
8) Kuroda K. Impaired endometrial function and unexplained recurrent pregnancy loss. Hypertens Res Preg 2019 ; 7 : 16-21.
9) Gellersen B, Brosens JJ. Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure. Endocrine Reviews 2014 ; 35 : 851-905.
10) Wilcox AJ, Baird DD, Wenberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999 ; 340 : 1796-9.
11) Wahabi HA, Fayed AA, Esmaeil SA, et al. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev. 2018 ; 8 : CD 005943.
12) Kuroda K. Previous Trial Studies of Unexplained Recurrent Miscarriage. In : Kuroda K, Brosens JJ, Quenby S, Takeda S, eds. Treatment Strategy for Unexplained Infertility and Recurrent Miscarriage. Singapore : Springer Singapore, 2018 : 85-94.
13) Connell MT, Szatkowski JM, Terry N, et al. Timing luteal support in assisted reproductive technology : a systematic review. Fertil Steril 2015 ; 103 : 939-46.e3.
14) Petersen JF, Andersen AN, Klein BM, et al. Luteal phase progesterone and oestradiol after ovarian stimulation : relation to response and prediction of pregnancy. Reprod Biomed Online 2018 ; 36 : 427-34.
15) Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation : a time to reconsider. Hum Reprod 2009 ; 24 : 2389-94.
16) Miles RA, Paulson RJ, Lobo RA, et al. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes : a comparative study. Fertil Steril 1994 ; 62 : 485-90.
18) Duijkers IJM, Klingmann I, Prinz R, et al. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo. Hum Reprod 2018 ; 33 : 2131-40.
P.200 掲載の参考文献
1) Dietterich C, Check JH et al : "Embryo Glue" does not seem to improve chances of subsequent pregnancy in refractory in vitro fertilization cases. Fertil Steril 2007 ; 87 : S 13-4.
2) Mansour R, Aboulghar M, et al : Dummy embryo transfer : a technique that minimizes the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilization. Fertil Steril 1990 ; 54 : 678-81.
3) Katariya KO, Bates GW, et al : Des the timing of mock embryo transfer affect in vitro fertilization implantation and pregnancy rates? Fertil Steril 2007 ; 88 : 1462-4.
4) Nazari A, Askari HA, et al : Embryo transfer technique as acause of ectopic pregnancy in in vitro fertilization. Fertil Steril 1993 ; 60 : 919-21.
5) Frankfurter D, Silva CP, Mota F, et al : The transfer point is aq novel measure of embryo placement. Fertil Steril 2003 ; 79 (6) : 1416-21.
6) Waterstone J, Curson R, Parsons J : Embryo transfer to low uterine cavity. Lancet 1991 ; 337 (8754) : 1413.
7) 日本産科婦人科学会 : 平成23年度倫理委員会登録・調査小委員会報告 (2010年分の体外受精・胚移植等の臨床実施成績および2012年7月における登録施設名). 日産婦誌 2012 ; 64 : 2110-40.
8) 後藤栄, 塩谷雅英 : 新しい胚移植法-子宮内膜刺激胚移植法 (SEET) 臨婦産2010 ; 64 (5) : 873-7.
9) Goto S, Takebayashi L, Shiotani M, et al : Effectivenessof 2-step (consecutive) embryo transfer. Comparison with cleavage-stage transfer. J Reprod Med 2003 ; 48 : 370-4.
10) Goto S, Shiotani M, Kitagawa M, et al : Effectiveness of two-step (consecutive) embryo transfer in patients who have two embryos on day 2 : comparison with cleavage-stage embryo transfer. Fertil Steril 2005 ; 83 (3) : 721-3.
11) 加藤修 : 経子宮筋層的内膜内胚埋め込み法 "The Towako Method". 臨婦産 1992 ; 46 (4) : 450-2.
12) Bontekoe, et al : Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane Database Syst Rev 2014 ; 25 : 2014 (2) : CD 007421.
P.206 掲載の参考文献
1) Bunge RG, Keettel WC, Sherman JK : Clinical use of frozen semen. Fertil Steril 1954 ; 5 : 520-9.
2) Whittingham DG, Leibo SP, Mazur P : Survival of mouse embryos frozen to 196 degrees and 269 degrees C. Science 1972 ; 178 : 411-4.
3) Trounson A, Mohr L : Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983 ; 305 : 707-9.
4) Chen C : Pregnancy after human oocyte cryopreservation. Lancet 1986 ; 1 : 884-6.
5) Rall WF, Fahy GM : Ice-free cryopreservation of mouse embryos by vitrification. Nature 1985 ; 313 : 573-5.
6) Cha KR, Hong SW, Chung HM, et al : Pregnancy and implantation from vitrified oocytes following in vitro fertilization (IVF) and in vitro culture (IVC). Fertil Steril 1999 ; 72 : S 2.
7) Kuleshova, L, Gianaroli L, Magli C, et al : Birth following vitrification of a small number of human oocytes : case report. Hum Reprod 1999 ; 14 : 3077-9.
8) Chen SU, Lien YR, Chao KH, et al : Cryopreservation of mature human oocytes by vitrification with ethylene glycol in straws. Fertil Steril 2000 ; 74 : 804-8.
9) Kuwayama M, Kato O : Successful vitrification of human oocytes. Fertil Steril 2000 ; 74 : S 49.
10) Cobo A, Diaz C : Clinical application of oocyte vitrification : a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011 ; 96 : 277-85.
11) Cobo A, Kuwayama M, Perez S, et al : Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008 ; 89 : 1657-64.
12) 香川則子, 桑山正成 : 卵子凍結保存と卵子バンク. 卵子学. 森崇英 編, 2011, 京都大学学術出版会, p 941-7.
13) Thurin A, Hausken J, Hillensjo T, et al : Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. N Engl J Med 2004 ; 351 : 2392-402.
14) The Practice Committees of the American Society for Reproductive Medicine : the Society for Assisted Reproductive Technology : Mature oocyte cryopreservation : a guideline. Fertil Steril 2013 ; 99 : 37-43.
15) ESHRE Task Force on Etics and Law, Dondorp W, de Wert G, Pennings G, et al : Oocyte cryopreservation for age-related fertility loss. Hum Reprod 2012 ; 27 : 1231-7.
16) Stoop D, Cobo A, Silber S : Fertility preservation for age-related fertility decline. Lancet 2014 ; 384 : 1311-9.
17) 日本生殖医学会・倫理委員会 (吉村泰典・理事長/石原理・倫理委員長) : 未受精卵子および卵巣組織の凍結・保存に関するガイドライン. 2013年 11月.
18) 日本産科婦人科学会 : 医学的適応による未受精卵子および卵巣組織の採取・凍結・保存に関する見解. 日産婦誌 2014 ; 66 : 1291-3.
19) ARTデータブック 2019年版. 日本産科婦人科学会登録・調査委員会報告. https://www.jsog.or.jp/activity/art/2019data_202107.pdf
20) Donnez J, Dolmans MM, Demylle D, et al : Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004 ; 364 : 1405-10.
21) Kikuchi I, Kagawa N, Silber S, et al : Oophorectomy for fertility preservation via reduced-port laparoscopic surgery. Surg Innov 2013 ; 20 : 219-24.
22) Sheshpari S, Shahnazi M, Mobarak H, et al : Ovarian function and reproductive outcome after ovarian tissue transplantation : a systematic review. J Transl Med 2019 ; 17 (1) : 396.
23) Devine K, Mumford SL, Goldman KN, et al : Baby budgeting : oocyte cryopreservation in women delaying reproduction can reduce cost per live birth. Fertil Steril 2015 ; 103 : 1446-53.
P.219 掲載の参考文献
1) Ishihara O, Jwa SC, Kuwahara A, et al : Assisted reproductive technology in Japan : A summary report for 2018 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol 2021 ; 20 : 3-12.
2) Segawa T, Kuroda T, Kato K, et al : Cytogenetic analysis of the retained products of conception after missed abortion following blastocyst transfer : a retrospective, large-scale, single-centre study. Reprod Biomed Online 2017 ; 34 : 203-10.
3) Yeh JS, Steward RG, Dude AM, et al : Pregnancy outcomes decline in recipients over age 44 : an analysis of 27, 959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology. Fertil Steril 2014 ; 101 : 1331-6.
4) Nishino T, Kamiguchi Y, Tateno H, et al : A cytogenetic study of human oocytes unfertilized in invitro fertilization (IVF). Nihon Sanka Fujinka Gakkai Zasshi 1994 ; 46 : 95-101.
5) Fusco P, Esposito MR, Tonini GP : Chromosome instability in neuroblastoma. Oncol Lett 2018 ; 16 : 6887-94.
6) Viotti M, Victor AR, Barnes FL, et al : Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril 2021 ; 115 : 1212-24.
7) Zhou S, Xie P, Zhang S, et al : Complex mosaic blastocysts after preimplantation genetic testing : prevalence and outcomes after re-biopsy and re-vitrification. Reprod Biomed Online 2021 ; 43 : 215-22.
8) PGDIS Newsletter : PGDIS position statement on chromosome mosaicism and preimplantation aneuploidy tesiting at the blastocyst stage. http://pgdisorg/docs/newsletter_071816html2016.
9) Gleicher N, Albertini DF, Barad DH, et al : The 2019 PGDIS position statement on transfer of mosaic embryos within a context of new information on PGT-A. Reprod Biol Endocrinol 2020 ; 18 : 57.
10) Harton GL, Munne S, Surrey M, et al : Diminished effect of maternal age on implantation after preimplantation genetic diagnosis with array comparative genomic hybridization. Fertil Steril 2013 ; 100 : 1695-703.
11) Greco E, Minasi MG, Fiorentino F : Healthy Babies after Intrauterine Transfer of Mosaic Aneuploid Blastocysts. N Engl J Med 2015 ; 373 : 2089-90.
12) Ma Y, Liu LW, Liu Y, et al : Which type of chromosomal mosaicism is compatible for embryo transfer : a systematical review and meta-analysis. Arch Gynecol Obstet 2022.
13) Kahraman S, Cetinkaya M, Yuksel B, et al : The birth of a baby with mosaicism resulting from a known mosaic embryo transfer : a case report. Hum Reprod 2020 ; 35 : 727-33.
14) Ikuma S, Sato T, Sugiura-Ogasawara M, et al : Preimplantation Genetic Diagnosis and Natural Conception : A Comparison of Live Birth Rates in Patients with Recurrent Pregnancy Loss Associated with Translocation. PLoS One 2015 ; 10 : e0129958.
P.227 掲載の参考文献
1) Harper JC, Wilton L, Traeger-Synodinos J, et al : The ESHRE PGD Consortium : 10 years of data collection. Hum Reprod Update 2012 ; 18 : 234-47.
P.237 掲載の参考文献
1) 厚生労働省 : 不妊治療に関する取組 不妊治療の保険適用に関する資料集 https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kodomo/kodomo_kosodate/boshi-hoken/funin-01.html.
2) Kuang Y, Chen Q, Fu Y, et al : Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2015 ; 104 : 62-70.e3.
3) Hu KL, Wang S, Ye X, et al : GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation : a systematic review and meta-analysis of randomized trials. Reprod Biol Endocrinol 2021 ; 19 : 78.
4) Kuroda K, Ikemoto Y, Ochiai A, et al : Combination treatment of preoperative embryo cryopreservation and endoscopic surgery (surgery-ART hybrid therapy) in infertile women with diminished ovarian reserve and uterine myomas or ovarian endometriomas. J Minim Invasive Gynecol 2019 ; 26, 1369-75.

各論2 疾患別の治療

P.244 掲載の参考文献
1) Nisolle M, Donnez J : Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997 ; 68 : 585-96.
2) Eskenazi B, Warner ML : Epidemiology of endometriosis. Obstet Gynecol Clin N Am 1997 ; 24 : 235-58.
3) Meuleman C, Vandenabeele B, Fieuws S, et al : High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril 2009 ; 92 : 68-74.
4) Sampson JA : Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. Am J Pathol 1927 ; 3 : 93-110.43.
5) Halme J, Hammond MG, Hulka JF, et al : Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984 ; 64 : 151-4.
6) Kuroda K, Kitade M, Kikuchi I, et al : Peritoneal Vascular Density Assessment Using Narrow-Band Imaging and Vascular Analysis Software, and Cytokine Analysis in Women with and without Endometriosis. J Minim Invasive Gynecol 2010 ; 17 : 21-5.
7) Harada T, Iwabe T, Terakawa N : Role of cytokines in endometriosis. Fertil Steril 2001 ; 76 : 1-10.
8) Hachisuga T, Kawarabayashi T : Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod 2002 ; 17 : 432-5.
9) Kuroda M, Kuroda K, Arakawa A, et al : Histological assessment of impact of ovarian endometrioma and laparoscopic cystectomy on ovarian reserve. J Obstet Gynaecol Res 2012 ; 38 : 1187-93.
10) McArthur JW, Ulfelder H : The effect of pregnancy upon endometriosis. Obstet Gynecol Surv 1965 ; 20 : 709-33.
11) Ueda Y, Enomoto T, Miyatake T, et al : A retrospective analysis of ovarian endometriosis during pregnancy. Fertil Steril 2010 ; 94 : 78-84.
12) Brosens I, Brosens JJ, Fusi L, et al : Risks of adverse pregnancy outcome in endometriosis. Fertil Steril 2012 ; 98 : 30-5.
13) Marcoux S, Maheux R, Berube S, et al : Laparoscopic surgery in infertile, women with minimal or mild endometriosis. N Engl J Med 1997 ; 337 : 217-22.
14) Alborzi S, Momtahan M, Parsanezhad ME, et al : A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril 2004 ; 82 : 1633-7.
15) Hart R, Hickey M, Maouris P, et al : Excisional surgery versus ablative surgery for ovarian endometriomata: a Cochrane Review. Hum Reprod 2005 ; 20 : 3000-7.
16) Demirol A, Guven S, Baykal C, et al : Effect of endometrioma cystectomy on IVF outcome : a prospective randomized study. Reprod Biomed Online 2006 ; 12 : 639-43.
17) Garcia-Velasco JA, Arici A : Surgery for the removal of endometriomas before in vitro fertilization does not increase implantation and pregnancy tests. Fertil Steril 2004 ; 81 : 1206.
18) Benschop L, Farquhar C, van der Poel N, et al : Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database of Syst Rev 2010 ; 11 : CD008571.
19) Kuroda K, Ikemoto Y, Ochiai A, et al : Combination treatment of preoperative embryo cryopreservation and endoscopic surgery (Surgery-ART Hybrid Therapy) in infertile women with diminished ovarian reserve and uterine myomas or ovarian endometriomas. J Minim Invasive Gynecol 2019 ; 26 : 1369-75.
20) Brosens IA, Puttemans PJ, Deprest J : The endoscopic localization of endometrial implants in the ovarian chocolate cyst. Fertil Steril 1994 ; 61 : 1034-8.
21) Brosens IA, VanBallaer P, Puttemans P, et al : Reconstruction of the ovary containing large endometriomas by an extraovarian endosurgical technique. Fertil Steril 1996 ; 66 : 517-21.
P.251 掲載の参考文献
1) Klatsky PC, Tran ND, Caughey AB, et al : Fibroids and reproductive outcomes : a systematic literature review from conception to delivery. Am J Obstet Gynecol 2008 ; 198 : 357-66.
2) Verkauf BS : Myomectomy for fertility enhancement and preservation. Fertil Steril 1992 ; 58 : 1-15.
3) Marret H, Fritel X, Ouldamer L, et al : Therapeutic management of uterine fibroid tumors : updated French guidelines. Eur J Obstet Gynecol Reprod Biol 2012 ; 165 : 156-64.
4) Exacoustos C, Rosati P : Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 1993 ; 82 : 97-101.
5) Broekmans FJ, Soules MR, Fauser BC : Ovarian aging : mechanisms and clinical consequences. Endocr Rev 2009 ; 30 : 465-93.
6) van Noord-Zaadstra BM, Looman CW, Alsbach H, et al : Delaying childbearing : effect of age on fecundity and outcome of pregnancy. BMJ 1991 ; 302 : 1361-5.
7) Faddy MJ, Gosden RG, Gougeon A, et al : Accelerated disappearance of ovarian follicles in mid-life : implications for forecasting menopause. Hum Reprod 1992 ; 7 : 1342-6.
8) Payson M, Leppert P, Segars J : Epidemiology of myomas. Obstet Gynecol Clin North Am 2006 ; 33 : 1-11.
9) Lieng M, Istre O, Langebrekke A : Uterine rupture after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 2004 ; 11 : 92-3.
10) Pistofidis G, Makrakis E, Balinakos P, et al : Report of 7 uterine rupture cases after laparoscopic myomectomy : update of the literature. J Minim Invasive Gynecol 2012 ; 19 : 762-7.
11) Nkemayim DC, Hammadeh ME, Hippach M, et al : Uterine rupture in pregnancy subsequent to previous laparoscopic electromyolysis. Case report and review of the literature. Arch Gynecol Obstet 2000 ; 264 : 154-6.
12) Toner JP, Grainger DA, Frazier LM, et al : Clinical outcomes among recipients of donated eggs : an analysis of the U.S. national experience, 1996? 1998. Fertil Steril 2002 ; 78 : 1038-45.
13) Kuroda K, Ikemoto Y, Ochiai A, et al : Combination Treatment of Preoperative Embryo Cryopreservation and Endoscopic Surgery (Surgery-ART Hybrid Therapy) in Infertile Women with Diminished Ovarian Reserve and Uterine Myomas or Ovarian Endometriomas. J Minim Invasive Gynecol 2019 ; 26 : 1369-75.
14) Kuroda K, Kitade M, Kikuchi I, et al : The impact of endometriosis, endometrioma and ovarian cystectomy on assisted reproductive technology. Reprod Med Biol 2009 ; 8 : 113-8.
15) Takeuchi H, Kuwatsuru R : The indications, surgical techniques, and limitations of laparoscopic myomectomy. JSLS 2003 ; 7 : 89-95.
16) 武内裕之 : 腹腔鏡手術の基本手技. 順天堂大学産婦人科内視鏡チームによる腹腔鏡手術マニュアル, 中外医学社, 2008.
P.258 掲載の参考文献
1) Upson K, Missmer SA : Epidemiology of Adenomyosis. Semin Reprod Med 2020 ; 38 (2-03) : 89-107.
2) Mehasseb MK, Bell SC, Pringle JH,et al : Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril 2010 ; 93 (7) : 2130-6.
3) Dueholm M, Lundorf E : Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol 2007 ; 19 (6) : 505-12.
4) Barbanti C, Centini G, Lazzeri L, et al : Adenomyosis and infertility : the role of the junctional zone. Gynecol Endocrinol 2021 ; 37 (7) : 577-83.
5) Vercellini P, Consonni D, Dridi D, et al : Uterine adenomyosis and in vitro fertilization outcome : a systematic review and meta-analysis. Human Reprod 2014 ; 29 (5) : 964-77.
6) Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, et al : Fertility, pregnancy and neonatal outcomes of patients with adenomyosis : a systematic review and meta-analysis. Reprod Biomed Online 2021 ; 42 (1) : 185-206.
7) Horton J, Sterrenburg M, Lane S, et al : Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis : a systematic review and meta-analysis. Human Reprod Update 2019 ; 25 (5) : 593-633.
8) Huang Y, Zhao X, Chen Y, et al : Miscarriage on endometriosis and adenomyosis in women by assisted reproductive technology or with spontaneous conception : A systematic review and meta-analysis. BioMed Research International 2020 ; 2020.
9) Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, et al : Fertility, pregnancy and neonatal outcomes of patients with adenomyosis : A systematic review and meta-analysis. Reprod Biomed Online 2021 ; 42 (1) : 185-206.
10) Martinez-Conejero JA, Morgan M, Montesinos M, et al : Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation. Fertil Steril 2011 ; 96 (4) : 943-U 401.
11) Tamura H, Kishi H, Kitade M, et al : Complications and outcomes of pregnant women with adenomyosis in Japan. Reprod Med Biol 2017 ; 16 (4) : 330-6.
12) Ma B, Zhu Y, Liu Y : Management of atypical polypoid adenomyoma of the uterus : A single center's experience. Medicine (Baltimore) 2018 ; 97 (12) : e0135.
13) Vannuccini S, Luisi S, Tosti C, et al : Role of medical therapy in the management of uterine adenomyosis. Fertil steril 2018 ; 109 (3) : 398-405.
14) Maheshwari A, Gurunath S, Fatima F, et al : Adenomyosis and subfertility : a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update 2012 ; 18 (4) : 374-92.
15) Li X, Pan N, Zhang W, et al : Association between uterine volume and pregnancy outcomes in adenomyosis patients undergoing frozen-thawed embryo transfer. Reprod Biomed Online 2021 ; 42 (2) : 384-9.
16) Wu Y, Huang J, Zhong G, et al : Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis. Reprod Biomed Online 2022 ; 44 (2) : 380-8.
17) Tan J, Moriarty S, Taskin O, et al : Reproductive Outcomes after Fertility-Sparing Surgery for Focal and Diffuse Adenomyosis : A Systematic Review. J Minim Invasive Gynecol 2018 ; 25 (4) : 608-21.
18) Grimbizis GF, Mikos T, Tarlatzis B ; Uterus-sparing operative treatment for adenomyosis. Fertil Steril 2014 ; 101 (2) : 472-87.
19) Osada H : Uterine adenomyosis and adenomyoma : the surgical approach. Fertil Steril 2018 ; 109 (3) : 406-17.
P.264 掲載の参考文献
1) Fox H, Buckley H : The endometrium. Fox H, Buckley H eds, Gynecological and Obstetric Pathology for the MRCOG and Beyond, RCOG Press, London 1998, 55-7.
2) Casini ML, Rossi F, Agostini R, et al : Effects of the position of fibroid on fertility. Gynecol Endo 2006 ; 22 : 106-9.
3) Farhi J, Ashkenazi J, Feldberg D, et al : Effect of uterine leiomyomata on the results of in vitro fertilization treatment. Hum Reprod 1995 ; 10 : 2576-8.
4) Giatras K, Noyes N, Licciardi F, et al : Fertility after hysteroscopic resection of submucous myomas. J Am Assoc Gynecol Laparosc 1999 ; 6 : 155-8.
5) Lefebvre G, Vilos G, Allaire C, et al : Clinical Practice Gynaecology Committee, Society for Obstetricians and Gynaecologists of Canada. The management of uterine leiomyomas. J Obstet Gynaecol Can 2003 ; 25 : 396-418.
6) Pitts EA, Parker WH, Olive DL : Fibroids and infertility : an update systematic review of the evidence. Fertil Steril 2009 ; 91 : 1215-23.
7) Spiewankiewicz B, Stelmachow J, Sawicki W, et al : The effectiveness of hysteroscopic polypectomy in cases of female infertility. Clin Exp Obstet Gynecol 2003 ; 30 : 23-5.
8) Adelson MG, Adelson K : Miscellaneous benign disorders of the upper genital tract. LJ Copeland, JF Jarrell eds. Textbook of Gynecology, WB Saunders, Philadelphia 2000, 725-6.
9) Varasteh NN, Neuwirth RS, Levin B, et al : Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 1999 ; 94 : 168-71.
10) Shokeir TA, Shalan HM, El-Shafei MM : Significance of endometrial polyps detected hysteroscopically in eumenorrheic infertile women. J Obstet Gynaecol Res 2004 ; 30 : 84-9.
11) Perez-Medina T, Bajo-Arenas J, Salazar F, et al : Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination : a prospective, randomized study. Hum Reprod 2005 ; 20 : 1632-5.
12) Stamatellos I, Apostolides A, Stamatopoulos P, et al : Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps. Arch Gynecol Obstet 2008 ; 277 : 395-9.
13) Valle RF : Therapeutic hysteroscopy in infertility. Int J Fertil 1984 ; 29 : 143-8.
14) Yanaihara A, Yorimitsu T, Motoyama H, et al : Location of endometrial polyp and pregnancy rate in infertility patients. Fertil Steril 2008 ; 90 : 180-2.
15) Klatsky PC, Tran ND, Caughey AB, et al : Fibroids and reproductive outcomes ; a systematic review from conception to delivery. Am J Obstet Gynecol 2008 ; 198 : 357-66.
16) Ezzati M, Norian J, Segars JH : Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Womens Health (Lond Engl) 2009 ; 5 : 413-21.
17) 齊藤寿一郎, 坂本愛子, 手島 薫 : [不妊女性に対する手術療法 適応・タイミングと手技のコツ] 子宮腔内病変に対する子宮鏡検査・治療 子宮粘膜下筋腫と子宮内膜ポリープを中心に. 臨婦産 2016 ; 70 : 166-71.
18) Pereira N, Petrini AC, Lekovich JP : Surgical Management of Endometrial Polyps in Infertile Women : A Comprehensive Review. Surg Res Pract 2015 ; 2015 : 914390.
19) Bettocchi S, Ceci O, Vicino M, et al : Diagnostic inadequacy of dilatation and curettage. Fertil Steril 2001 ; 75 : 803-5.
20) Loffer FD : Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding : the value of a negative hysteroscopic view. Obstet Gynecol 1989 ; 73 : 16-20.
21) Preutthipan S, Herabutya Y : Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women. Fertil Steril 2005 ; 83 : 705-9.
22) Wada-Hiraike O, Osuga Y, Hiroi H, et al : Sessile polyps and pedunculated polyps respond differently to oral contraceptives. Gynecol Endocrinol 2011 ; 27 : 351-5.
23) 三沢昭彦, 林博, 加藤淳子ほか : 当院における子宮鏡下粘膜下筋腫核出術後の不妊治療成績および妊娠・分娩予後. 産婦の実際 2009 ; 58 : 257-61.
P.273 掲載の参考文献
1) March WA, Moore VM, Willson KJ, et al : The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010 ; 25 : 544.
2) ESHRE Capri Workshop Group : Health and fertility in World Health Organization group anovulatory women. Hum Reprod Update 2012 ; 18 : 586-99.
3) Balen AH, Rutherford AJ : Managing anovulatory infertility and polycystic ovary syndrome. BMJ 2007 ; 335 : 663-6.
4) Lebbe M, Woodruff TK : Involvement of androgens in ovarian health and disease. Mol Hum Reprod 2013 ; 19 : 828-37.
5) Agarwal SK, Judd HL, Magoffin DA : A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J CIin Endocrinol Metab 1996 ; 81 : 686-91.
6) Dumont A, Robin G, Catteau-Jonard S, et al : Role of Anti-Mullerian Hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome : a review. Reprod Bio Endocrinol 2015 ; 13 : 137.
7) Nestler JE, Jakubowicz DJ, de Vargas AF, et al : Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 1998 ; 83 : 2001-5.
8) Rai R, Backos M, Rushworth F, et al : Polycystic ovaries and recurrent miscarriage-a reappraisal. Hum Reprod 2000 ; 15 : 612-5.
9) Qin JZ, Pang LH, Li MJ, et al : Obstetric complications in women with polycystic ovary syndrome : a systematic review and meta-analysis. Reprod Biol Endocrinol 2013 ; 11 : 56.
10) 生殖内分泌委員会 本邦における多嚢胞性卵巣症候群の新しい診断基準の設定に関する小委員会 : 平成17年度~平成18年度検討結果報告. 日産婦誌 2007 ; 59 : 868-86.
11) Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group : Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 ; 81 : 19-25.
12) Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group : Consensus on infertility treatment related to polycystic ovary symdrome. Fertil Steril 2008 ; 89 : 505-22.
13) Kathrine Birch Petersen, Nina Gros Pedersen, Antte Tonnes Pedersen, et al : Mono-ovulation in women with polycystic ovary syndrome : a clinical review on ovulation induction. Reprod biomed Online 2016 ; 32 : 563-83.
14) Palomba S : Aromatase inhinitors for ovulation induction. J Clin Endocrinol Metab 2015 ; 100 : 1742-7.
15) Ramezanzadeh F, Nasiri R, Sarafraz yazdi M, et al : A randomized trial of ovulation induction with two different doses of letrozole in women with PCOS. Arch Gynecol Obset 2011 ; 284 : 29-34.
16) Homburg R, Howles CM : Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome : rationale, results, reflections and refinements. Hum Reprod Update 1999 ; 5 : 493-9.
17) Abu Hashim H, Al-Inany H, De Vos M, et al : Three decades after Gjonnaess's laparoscopic ovarian drilling for treatment of PCOS ; what do we know? An evidence-based approach. Arch Gynecol Obstet 2013 ; 288 : 409-22.
18) Abu Hashim H : Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome : an evidence-based approach. Arch Gynecol Obstet 2015 ; 291 : 11-8.
19) Ashraf I Elmashad : Impact of laparoscopic ovarian drilling on anti-Mullerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome. Fertil Steril 2011 ; 95 (7) : 2342-6.
20) Saad A Amer, Tarek T El Shamy, Cathryn James, et al : The impact of laparoscopic ovarian drilling on AMH and ovarian reserve : a meta-analysis. Reproduction 2017 ; 154 (1) : 13-21.
21) Dumont A, Robin G, Ctteau-Jonard S, et al : Role of Anti-Mullerian Hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome : a review. Repro Bio Endocrinol 2015 ; 13 : 137.
P.280 掲載の参考文献
1) 岩佐武, 松崎利也, 苛原稔 : 中枢性月経異常. 臨婦産 2016 ; 70 : 481-5.
2) 能瀬さやか : 思春期・アスリートの月経異常と健康管理. 今日の治療指針 2021年版, 20210101.
3) Yoshioka W, Amino N, Ide A, et al : Thyroxine treatment may be useful for subclinical hypothyroidism in patients with female infertility. Endocr J 2015 ; 62 : 87-92.
4) 中川浩次, 岩崎稚子, 河内谷敏ほか : hMG製剤を用いたlow-dose step up法による排卵誘発により妊娠に至った下垂体性性腺機能不全の1例. 産と婦 2005 ; 72 : 119-22.
5) Du X, Yuan Q, Yao Y, et al : Hypopituitarism and successful pregnancy. Int J Clin Exp Med 2014 ; 7 : 4660-5.
6) Shufelt CL, Torbati T, Dutra E : Hypothalamic Amenorrhea and the Long-Term Health Consequences. Semin Reprod Med 2017 ; 35 : 256-62.
7) Veleva Z, Tiitinen A, Vilska S, et al : High and low BMI increase the risk of miscarriage after IVF/ICSI and FET. Hum Reprod 2008 ; 23 : 878-84.
8) Schleusner E : The prevention, diagnosis and treatment of premature labor. Dtsch Arztebl Int 2013 ; 110 : 227-35.
9) Aladashvili-Chikvaidze N, Kristesashvili J, Gegechkori M : Types of reproductive disorders in underweight and overweight young females and correlations of respective hormonal changes with BMI. Iran J Reprod Med 2015 ; 13 : 135-40.
10) Kuubler K, Klingmuuller D, Gembruch U, et al : High-risk pregnancy management in women with hypopituitarism. J Perinatol 2009 ; 29 : 89-95.
11) de Ziegler D, Streuli I, Meldrum DR, et al : The value of growth hormone supplements in ART for poor ovarian responders. Fertil Steril 2011 ; 96 : 1069-76.
12) Daniel A, Ezzat S, Greenblatt E : Adjuvant growth hormone for ovulation induction with gonadotropins in the treatment of a woman with hypopituitarism. Case Rep Endocrinol 2012 : 356429.
13) 千石一雄, 宮本敏伸, 大石由利子 : 内分泌疾患に強くなる 専門医に学ぶ内分泌疾患の診断・治療 [性腺疾患〕女性性腺機能低下症. Medicina 2013 ; 50 : 1832-5.
14) Papaleo E, Alviggi C, Colombo GL, et al : Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal woman. Ther Clin Risk Manag 2014 ; 10 : 479-84.
15) 都築朋子,吉村智雄,岡田英孝 : 一般不妊治療 : 薬物療法 ゴナドトロピン療法の投与法の種類と特徴. 臨婦産 2016 ; 70 : 134-7.
16) Kuroda K, Ezoe K, Kato K, et al : Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism. J Obstet Gynaecol Res 2018 ; 44 : 922-8.
17) Sophie Gibson ME, Fleming N, Zuijdwijk, et al : Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea. J Clin Res Pediatr Endocrinol 2020 ; 12 : 18-27.
18) 都築朋子, 吉村智雄, 岡田英孝 : 一般不妊治療 : 薬物療法 Q4 体重減少性無月経患者のゴナドトロピン療法がうまくいきません. 有効な卵巣刺激法について教えてください. 臨婦産 2016 ; 70 : 148-9.
P.287 掲載の参考文献
1) Faddy MJ, Gosden RG, Gougeon A et al. Accelerated disappearance of ovarian follicles in mid-life : implications for forecasting menopause. Hum Reprod 1992 ; 7 : 1342-6.
2) Golezar S, Ramezani Tehrani F et al. The global prevalence of primary ovarian insufficiency and early menopause : a meta-analysis. Climacteric 2019 ; 22 : 403-11.
3) Webber L, Davies M, Anderson R et al. ESHRE Guideline : management of women with premature ovarian insufficiency. Hum Reprod 2016 ; 31 : 926-37.
4) Fenton AJ. Premature ovarian insufficiency : Pathogenesis and management. J Midlife Health 2015 ; 6 : 147-53.
5) Bunnewell SJ, Honess ER, Karia AM et al. Diminished ovarian reserve in recurrent pregnancy loss : a systematic review and meta-analysis. Fertil Steril 2020 ; 113 : 818-27.e3.
6) Moridi I, Chen A, Tal O et al. The Association between Vitamin D and Anti-Mullerian Hormone : A Systematic Review and Meta-Analysis. Nutrients 2020 ; 12 : 1567.
7) Surrey ES, Cedars MI. The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertil Steril 1989 ; 52 : 36-41.
8) Dragojevic-Dikic S, Rakic S, Nikolic B et al. Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure. Gynecol Endocrinol 2009 ; 25 : 769-72.
9) Vandborg M, Lauszus FF. Premature ovarian failure and pregnancy. Arch Gynecol Obstet 2006 ; 273 : 387-8.
10) Laml T, Huber JC, Albrecht AE et al. Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrhea. Gynecol Endocrinol 1999 ; 13 : 89-92.
11) Bidet M, Bachelot A, Bissauge E et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011 ; 96 : 3864-72.
12) Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders : is there any light at the end of the tunnel? Fertil Steril 2011 ; 96 : 1058-U 253.
13) Galey-Fontaine J. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online 2005 ; 10 : 94-9.
14) Kuroda K, Kitade M, Kumakiri J et al. Minimum ovarian stimulation involving combined clomiphene citrate and estradiol treatment for in vitro fertilization of Bologna-criteria poor ovarian responders. J Obstetrics Gynaecol Research 2016 ; 42 : 178-83.
15) Monteiro CS, Scheffer BB, Carvalho RF et al. The impact of dehydroepiandrosterone in poor ovarian responders on assisted reproduction technology treatment. JBRA 2019 ; 23 : 414-7.
16) Zhang Y, Zhang C, Shu J et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF : a systematic review and network meta-analysis. Hum Reprod Update 2020 ; 26 : 247-63.
17) Bayoumi YA, Dakhly DM, Bassiouny YA et al. Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response. Int J Gynaecol Obstet 2015 ; 131 : 305-8.
18) Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007 ; 7 Suppl : S 41-50.
19) Xu Y, Nisenblat V, Lu C et al. Pretreatment with coenzyme Q 10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve : a randomized controlled trial. Reprod Biol Endocrinol 2018 ; 16 : 29.
20) Neves AR, Lucio M, Lima JL et al. Resveratrol in medicinal chemistry : a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 2012 ; 19 : 1663-81.
21) Tatone C, Di Emidio G, Barbonetti A et al. Sirtuins in gamete biology and reproductive physiology : emerging roles and therapeutic potential in female and male infertility. Hum Reprod Update 2018 ; 24 : 267-89.
22) Kuroda K, Ochiai A, Brosens JJ. The actions of resveratrol in decidualizing endometrium : acceleration or inhibition?†. Biol Reprod 2020 ; 103 : 1152-6.
23) Gerli S, Della Morte C, Ceccobelli M et al. Biological and clinical effects of a resveratrol-based multivitamin supplement on intracytoplasmic sperm injection cycles : a single-center, randomized controlled trial. J Matern Fetal Neonatal Med 2021 : 1-9.
24) Dennis NA, Houghton LA, Jones GT et al. The level of serum anti-Mullerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab 2012 ; 97 : 2450-5.
25) Kebapcilar AG, Kulaksizoglu M, Kebapcilar L et al. Is there a link between premature ovarian failure and serum concentrations of vitamin D, zinc, and copper? Menopause 2013 ; 20 : 94-9.
26) Cakiroglu Y, Saltik A, Yuceturk A et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging 2020 ; 12 : 10211-22.
27) Hajipour H, Farzadi L, Latifi Z et al. An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities : clinical and molecular aspects. Syst Biol Reprod Med 2021 ; 67 : 177-88.
28) Atkinson L, Martin F, Sturmey RG. Intraovarian injection of platelet-rich plasma in assisted reproduction : too much too soon? Hum Reprod 2021 ; 36 : 1737-50.
29) セントマザー産婦人科医院 : 新しい卵巣機能低下の回復法 2022年. https://www.stmother.com/treatment/ransou/
30) Umehara T, Urabe N, Obata T et al. Cutting the ovarian surface improves the responsiveness to exogenous hormonal treatment in aged mice. Reprod Med Biol 2020 ; 19 : 415-24.
31) 日本産科婦人科学会 提供配偶子を用いる生殖医療に関する検討委員会「精子・卵子・胚の提供等による生殖補助医療制度の整備に関する提案書」2021年 https://www.jsog.or.jp/news/pdf/20210608_shuuchiirai.pdf
P.297 掲載の参考文献
1) NICE : National Institute for Health and Clinical Excellence. National Collaborating Centre for Women's and Children's Health. Fertility : Assessment and Treatment for People with Fertility Problems 2013 ; 156 : 63.
2) Practice Comm Amer Soc Reprod M : Effectiveness and treatment for unexplained infertility. Fertil Steril 2006 ; 86 : S 111-4.
3) Somigliana E PA, Busnelli A, Filippi F, et al : Age-related infertility and unexplained infertility : an intricate clinical dilemma. Human Reprod 2016 ; 31 : 1390-6.
4) Harada T, Iwabe T, Terakawa N : Role of cytokines in endometriosis. Fertil Steril 2001 ; 76 : 1-10.
5) Marcoux S, Maheux R, Berube S, et al : Laparoscopic surgery in infertile, women with minimal or mild endometriosis. N Engl J Med 1997 ; 337 : 217-22.
6) Tanahatoe SJ, Hompes PGA, Lambalk CB : Investigation of the infertile couple-Should diagnostic laparoscopy be performed in the infertility work up programme in patients undergoing intrauterine insemination? Human Reprod 2003 ; 18 : 8-11.
7) Kuroda K : Sperm Factor, PLC, and Egg Activation. J Mammalian Ova Research 2010 ; 27 : 198-203.
8) 柳田薫, 高田智 : 顕微授精での受精障害. 医学のあゆみ 2007 ; 223 : 85-9.
9) Kashir J, Heindryckx B, Jones C, et al : Oocyte activation, phospholipase C zeta and human infertility. Hum Reprod Update 2010 ; 16 : 690-703.
10) Coughlan C, Ledger W, Wang Q, et al : Recurrent implantation failure : definition and management. Reprod Biomed Online 2014 ; 28 : 14-38.
11) Maleki-Hajiagha A, Razavi M, Rouholamin S, et al : Intrauterine infusion of autologous platelet-rich plasma in women undergoing assisted reproduction : A systematic review and meta-analysis. J Reprod Immunol 2020 ; 137 : 103078.
12) Moreno I, Codoner FM, Vilella F, et al : Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol 2016 ; 215 : 684-703.
13) Kadogami D, Nakaoka Y, Morimoto Y : Use of a vaginal probiotic suppository and antibiotics to influence the composition of the endometrial microbiota. Reprod Biol 2020 ; 20 : 307-14.
14) Tanimura S, Funamoto H, Hosono T, et al : New diagnostic criteria and operative strategy for cesarean scar syndrome : Endoscopic repair for secondary infertility caused by cesarean scar defect. J Obstet Gynaecol Res 2015 ; 41 : 1363-9.
15) Ikemoto Y, Kuroda K, Nakagawa K, et al : Vitamin D Regulates Maternal T-Helper Cytokine Production in Infertile Women. Nutrients 2018 ; 10 : 902.
16) Fabris A, Pacheco A, Cruz M, et al : Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients. Fertil Steril 2014 ; 102 : 1608-12.
17) Nakagawa K, Kwak-Kim J, Ota K, et al : Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH 1/TH 2 cell ratios. Am J Reprod Immunol 2015 ; 73 : 353-61.
18) Winger EE, Reed JL, Ashoush S, et al : Degree of TNF- α/IL- 10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol 2011 ; 65 : 610-8.
19) Garrido-Gomez T, Ruiz-Alonso M, Blesa D, et al : Profiling the gene signature of endometrial receptivity : clinical results. Fertil Steril 2013 ; 99 : 1078-85.
20) Tan J, Kan A, Hitkari J, et al : The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers. J Assist Reprod Genet 2018 ; 35 : 683-92.
21) Neves AR, Devesa M, Martinez F, et al : What is the clinical impact of the endometrial receptivity array in PGT-A and oocyte donation cycles? J Assist Reprod Genet 2019 ; 36 : 1901-8.
22) Kuroda K, Horikawa T, Moriyama A, et al : Impact of chronic endometritis on endometrial receptivity analysis results and pregnancy outcomes. Immun Inflamm Dis 2020 ; 8 : 650-8.
23) Velkeniers B, Van Meerhaeghe A, Poppe K, et al : Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies : systematic review and meta-analysis of RCTs. Hum Reprod Update 2013 ; 19 : 251-8.
24) Kuroda K, Matsumura Y, Ikemoto Y, et al : Analysis of the risk factors and treatment for repeated implantation failure : OPtimization of Thyroid function, IMmunity, and Uterine Milieu (OPTIMUM) treatment strategy. Am J Reprod Immunol 2021 ; 85 : e13376.
P.303 掲載の参考文献
1) Balercia G, Buldreghini E, Vignini A, et al : Coenzyme Q 10 treatment in infertile men with idiopathic asthenozoospermia : a placebo-controlled, double-blind randomized trial. Fertil Steril 2009 ; 91 : 1785-92.
2) Lenzi A, Lombardo F, Sgro P, et al : Use of carnitine therapy in selected cases of male factor infertility : a double-blind crossover trial. Fertil Steril 2003 ; 79 : 292-300.
3) Ebisch IMW, Pierik FH, Jong FHD, et al : Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl 2006 ; 29 : 339-45.
4) Tsujimura A, Hiramatsu I, Miyoshi M, et al : Relationship between serum zinc concentration and semen quality in newly-wed men. Int J Urol 2021 ; 28 : 289-93.
5) Terai K, Horie S, Fukuhara S, et al : Combination therapy with antioxidants improves total motile sperm counts : A Preliminary Study. Reprod Med Biol 2019 ; 19 : 89-94.
6) ElSheikh MG, Hosny MB, Elshenoufy A, et al : Combination of vitamin E and clomiphene citrate in treating patients with idiopathic oligoasthenozoospermia : A prospective, randomized trial. Andrology 2015 ; 3 : 864-7.
7) Cayan S, Shavakhabov S, Kadioglu A : Treatment of palpable varicocele in infertile men : a meta-analysis to define the best technique. J Androl 2009 ; 30 : 33-40.
8) Abdel-Meguid TA, Al-Sayyad A, Tayib A, et al : Does varicocele repair improve male infertility? An evidence-based perspective from a randomized, controlled trial. Eur Urol 2011 ; 59 : 455-61.
9) Taniguchi H, Iwamoto T, Ichikawa T, et al : Male Infertility Surgical Forum in Japan : Contemporary outcomes of seminal tract re-anastomoses for obstructive azoospermia : a nationwideJapanese survey. Int J Urol 2015 ; 22 : 213-8.
10) Aksglaede L, Juul A : Testicular function and fertility in men with Klinefelter syndrome : a review Eur J Endocrinol 2013 ; 168 : R 67-76.
P.311 掲載の参考文献
1) Capmas P, Suarthana E, Tulandi T : Management of Hydrosalpinx in the Era of Assisted Reproductive Technology : A Systematic Review and Meta-analysis. J Minim Invasive Gynecol 2021 ; 28 : 418-41.
2) Holzer I, Ott J, Kurz C, et al : Is Chronic Endometritis Associated with Tubal Infertility? A Prospective Cohort Study. J Minim Invasive Gynecol 2021 ; 28 (11) : 1876-81.
3) Harada T, Iwabe T, Terakawa N : Role of cytokines in endometriosis. Fertil Steril 2001 ; 76 : 1-10.
4) Taylor RC, Berkowitz J, McComb PF : Role of laparoscopic salpingostomy in the treatment of hydrosalpinx. Fertil Steril 2001 ; 75 : 594-600.
5) Kuroda K, Takeuchi H, Kitade M, et al : Assessment of tubal disorder as a risk factor for repeat ectopic pregnancy after laparoscopic surgery for tubal pregnancy. J Obstet Gynaecol Res 2009 ; 35 : 520-4.
6) Mekaru K, Kamiyama S, Masamoto H, et al : Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium. Gynecol Endocrinol 2008 ; 24 : 498-501.
7) Swart P, Mol BW, van der Veen F, et al : The accuracy of hysterosalpingography in the diagnosis of tubal pathology : a meta-analysis. Fertil Steril 1995 ; 64 : 486-91.
8) Dessole S, Meloni GB, Capobianco G, et al : A second hysterosalpingography reduces the use of selective technique for treatment of a proximal tubal obstruction. Fertil Steril 2000 ; 73 : 1037-9.
9) Dreyer K, van Rijswijk J, Mijatovic V, et al : Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women. N Engl J Med 2017 ; 376 : 2043-52.
10) Exacoustos C, Zupi E, Carusotti C, et al : Hysterosalpingo-contrast sonography compared with hysterosalpingography and laparoscopic dye pertubation to evaluate tubal patency. J Am Assoc Gynecol Laparosc 2003 ; 10 : 367-72.
11) Ikemoto Y, Kuroda K, Kuribayashi Y, et al : Tubal Function Abnormalities with Tubal Patency in Unexplained Infertility. In : Kuroda K, Brosens JJ, Quenby S, Takeda S, eds : Treatment Strategy for Unexplained Infertility and Recurrent Miscarriage, Singapore : Springer Singapore, 2018, p 19-31.
12) Tanaka Y, Tajima H, Sakuraba S, et al : Renaissance of surgical recanalization for proximal fallopian tubal occlusion : falloposcopic tuboplasty as a promising therapeutic option in tubal infertility. J Minim Invasive Gynecol 2011 ; 18 : 651-9.
13) Hou HY, Chen YQ, Li TC, et al : Outcome of laparoscopy-guided hysteroscopic tubal catheterization for infertility due to proximal tubal obstruction. J Minim Invasive Gynecol 2014 ; 21 : 272-8.
14) Harb H, Al-Rshoud F, Karunakaran B, et al : Hydrosalpinx and pregnancy loss : a systematic review and meta-analysis. Reprod Biomed Online 2019 ; 38 : 427-41.
15) Tsiami A, Chaimani A, Mavridis D, et al : Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer : a network meta-analysis. Ultrasound Obstet Gynecol 2016 ; 48 : 434-45.
16) Wu S, Zhang Q, Li Y : Effect comparison of salpingectomy versus proximal tubal occlusion on ovarian reserve : A meta-analysis. Medicine (Baltimore) 2020 ; 99 : e20601.
17) Xu B, Zhang Q, Zhao J, et al : Pregnancy outcome of in vitro fertilization after Essure and laparoscopic management of hydrosalpinx : a systematic review and meta-analysis. Fertil Steril 2017 ; 108 : 84-95.e5.
18) Franjoine SE, Bedaiwy MA, AbdelHafez FF, et al : Clinical Effectiveness of Modified Laparoscopic Fimbrioplasty for the Treatment of Minimal Endometriosis and Unexplained Infertility. Minim Invasive Surg 2015 ; 2015 : 730513.
19) Muller V, Makhmadalieva M, Kogan I, et al : Ectopic pregnancy following in vitro fertilization : meta-analysis and single-center experience during 6 years. Gynecol Endocrinol 2016 ; 32 (sup2) : 69-74.
P.316 掲載の参考文献
1) Johnston-MacAnanny EB, Hartnett J, Engmann LL, et al : Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril 2010 ; 93 : 437-41.
2) Kushnir VA, Solouki S, Sarig-Meth T, et al : Systemic Inflammation and Autoimmunity in Women with Chronic Endometritis. Am J Reprod Immunol 2016 ; 75 : 672-7.
3) Kuroda K, Matsumura Y, Ikemoto Y, et al : Analysis of the risk factors and treatment for repeated implantation failure : OPtimization of Thyroid function, IMmunity and Uterine Milieu (OPTIMUM) treatment strategy. Am J Reprod Immunol 2021 ; 85 : e13376.
4) Wu D, Kimura F, Zheng L, et al : Chronic endometritis modifies decidualization in human endometrial stromal cells. Reprod Biol Endocrinol 2017 ; 15 : 16.
5) Kuroda K, Horikawa T, Moriyama A, et al : Impact of chronic endometritis on endometrial receptivity analysis results and pregnancy outcomes. Immun Inflamm Dis 2020 ; 8 : 650-8.
6) Kasius JC, Fatemi HM, Bourgain C, et al : The impact of chronic endometritis on reproductive outcome. Fertil Steril 2011 ; 96 : 1451-6.
7) Vitagliano A, Saccardi C, Noventa M, et al : Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure : a systematic review and meta-analysis. Fertil Steril 2018 ; 110 : 103-12.e1.
8) McQueen DB, Perfetto CO, Hazard FK, et al : Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril 2015 ; 104 : 927-31.
9) Zolghadri J, Momtahan M, Aminian K, et al : The value of hysteroscopy in diagnosis of chronic endometritis in patients with unexplained recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 2011 ; 155 : 217-20.
10) Bouet PE, El Hachem H, Monceau E, et al : Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure : prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril 2016 ; 105 : 106-10.
11) Quenby S, Kalumbi C, Bates M, et al : Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 2005 ; 84 : 980-4.
12) Quenby S, Nik H, Innes B, et al : Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod 2009 ; 24 : 45-54.
13) Clifford K, Flanagan AM, Regan L : Endometrial CD56+ natural killer cells in women with recurrent miscarriage : a histomorphometric study. Hum Reprod 1999 ; 14 : 2727-30.
14) Morimune A, Kimura F, Nakamura A, et al : The effects of chronic endometritis on the pregnancy outcomes. Am J Reprod Immunol 2021 ; 85 : e13357.
15) Cicinelli E, Resta L, Nicoletti R, et al : Detection of chronic endometritis at fluid hysteroscopy. J Minim Invasive Gynecol 2005 ; 12 : 514-8.
16) Kuroda K, Yamashita S : Implantation Failure 1 : Intrauterine Circumstances and Embryo-Endometrium Synchrony at Implantation. In : Kuroda K, Brosens JJ, Quenby S, Takeda S, eds : Treatment Strategy for Unexplained Infertility and Recurrent Miscarriage, Singapore : Springer Singapore, 2018, p 33-43.
17) Kitaya K, Matsubayashi H, Takaya Y, et al : Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure. Am J Reprod Immunol 2017 ; 78 : e12719.
18) Liu Y, Ko EY, Wong KK, et al : Endometrial microbiota in infertile women with and without chronic endometritis as diagnosed using a quantitative and reference range-based method. Fertil Steril 2019 ; 112 : 707-17.e1.
19) Kuroda K, Takamizawa S, Motoyama H, et al : Analysis of the therapeutic effects of hysteroscopic polypectomy with and without doxycycline treatment on chronic endometritis with endometrial polyps. Am J Reprod Immunol 2021 ; 85 : e13392.
20) Salim R, Ben-Shlomo I, Colodner R, et al : Bacterial colonization of the uterine cervix and success rate in assisted reproduction : results of a prospective survey. Hum Reprod 2002 ; 17 : 337-40.
21) Moreno I, Codoner FM, Vilella F, et al : Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol 2016 ; 215 : 684-703.
22) Franasiak JM, Werner MD, Juneau CR, et al : Endometrial microbiome at the time of embryo transfer : next-generation sequencing of the 16 S ribosomal subunit. J Assist Reprod Genet 2016 ; 33 : 129-36.
23) Hashimoto T, Kyono K : Does dysbiotic endometrium affect blastocyst implantation in IVF patients? J Assist Reprod Genet 2019 ; 36 : 2471-9.
24) Ichiyama T, Kuroda K, Nagai Y, et al : Analysis of vaginal and endometrial microbiota communities in infertile women with a history of repeated implantation failure. Reprod Med Biol 2021 ; 20 : 334-44.
25) Chen C, Song X, Wei W, et al : The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun 2017 ; 8 : 875.
P.322 掲載の参考文献
1) The American Fertility Society : The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Mullerian anomalies and intrauterine adhesions. Fertil Steril 1988 ; 49 : 944-55.
2) Practice Committee of the American Society for Reproductive Medicine : Uterine septum : a guideline. Fertil Steril 2016 ; 106 : 530-40.
3) Chan YY, Jayaprakasan K, Tan A, et al : Reproductive outcomes in women with congenital uterine anomalies : a systematic review. Ultrasound Obstet Gynecol 2011 ; 38 : 371-82.
4) Saravelos SH, Cocksedge KA, Li TC : Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure : a critical appraisal. Hum Reprod Update 2008 ; 14 : 415-29.
5) Woelfer B, Salim R, Banerjee S, et al : Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol 2001 ; 98 : 1099-103.
6) 西田正人 : 子宮形成術の適応と実際. 産婦治療 2004 ; 88 : 495-503.
7) Grimbizis GF, Camus M, Tarlatzis BC, et al : Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001 ; 7 : 161-74.
8) Rikken JFW, Kowalik CR, Emanuel MH, et al : Septum resection versus expectant management in women with a septate uterus : an international multicentre open-label randomized controlled trial. Hum Reprod 2021 ; 36 : 1260-7.
P.330 掲載の参考文献
1) Krassas GE, Poppe K, Glinoer D : Thyroid function and human reproductive health. Endocr Rev 2010 ; 31 : 702-55.
2) Velkeniers B, Van Meerhaeghe A, Poppe K, et al : Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies : systematic review and meta-analysis of RCTs. Hum Reprod Update 2013 ; 19 : 251-8.
3) Poppe K, Glinoer D : Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update 2003 ; 9 : 149-61.
4) Alexander EK, Pearce EN, Brent GA, et al : 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 201 ; 27 : 315-89.
5) Cramer DW, Sluss PM, Powers RD, et al : Serum prolactin and TSH in an in vitro fertilization population : is there a link between fertilization and thyroid function? J Assist Reprod Genet 2003 ; 20 : 210-5.
6) Kuroda K, Uchida T, Nagai S, et al : Elevated serum thyroid-stimulating hormone is associated with decreased anti-Mullerian hormone in infertile women of reproductive age. J Assist Reprod Genet 2015 ; 32 : 243-7.
7) Michalakis KG, Mesen TB, Brayboy LM, et al : Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes. Fertil Steril 2011 ; 95 : 2634-7.
8) Colicchia M, Campagnolo L, Baldini E, et al : Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update 2014 ; 20 : 884-904.
9) Fedail JS, Zheng K, Wei Q, et al : Roles of thyroid hormones in follicular development in the ovary of neonatal and immature rats. Endocrine 2014 ; 46 : 594-604.
10) Panesar NS, Li CY, Rogers MS : Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem 2001 ; 38 : 329-32.
11) de Escobar GM, Obregon MJ, del Rey FE : Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000 ; 85 : 3975-87.
12) van den Boogaard E, Vissenberg R, Land JA, et al : Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy : a systematic review. Hum Reprod Update 2011 ; 17 : 605-19.
13) Haddow JE, Palomaki GE, Allan WC, et al : Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999 ; 341 : 549-55.
14) Kaneshige T, Arata N, Harada S, et al : Changes in serum iodine concentration, urinary iodine excretion and thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium (lipiodol). J Clin Endocrinol Metab 2015 ; 100 : E 469-72.
15) Mekaru K, Kamiyama S, Masamoto H, et al : Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium. Gynecol Endocrinol 2008 ; 24 : 498-501.
P.336 掲載の参考文献
1) 「不育症管理に関する提言」改訂委員会 : 不育症管理に関する提言 2021. 成育疾患克服等次世代育成基盤研究事業 令和2年度厚生労働科学研究.
2) Robertson L, Wu O, Langhorne P, et al : Thrombophilia in pregnancy : A systematic review. Br J Haematol 2006 ; 132 : 171-96.
3) The ESHRE Guideline Group on RPL : ESHRE guideline : recurrent pregnancy loss Human Reproduction Open. 2018, p 1-12. Doi : 10.1093/hropen/hoy004.
4) American College of Chest Physicians Evidence-Based Clnical Practice Guidelines (9 th Edition) : Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. Practice Guideline 2012 ; 141 : e691 S-e736 S.
5) Sebire NJ, Backos M, Goldin RD, et al : Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. Br J Obstet Gynaecol 2002 ; 109 : 570-3.
6) Vogt E, Ng AK, Rote NS : A model for the antiphospholipid antibody syndrome : monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996 ; 174 : 700-7.
7) Sugimura M, Kobayashi T, Shu F, et al : Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta 1999 ; 20 : 555-60.
8) Shu F, Sugimura M, Kanayama N, et al : Imunohistochemical study of annexin V expression in placentae of preeclampsia. Gynecol Obstet Invest 2000 ; 49 : 17-23.
9) 日本産科婦人科学会/日本産婦人科医会編 : CQ204 反復・習慣流産患者の診断と取扱いは? 産婦人科診療ガイドライン-産科編 2020, 日本産科婦人科学会, 2020, p 119-25.
10) Miyakis S, Lockshin MD, Atsumi T, et al : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4 : 295-306.
11) de Jong PG, Kaandorp S, Di Nisio M, et al : Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev 2014 ; (7) : CD 004734.
12) Hamulyak EN, Scheres LJJ, Marijnen MC, et al : Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database Syst Rev 2020 ; (5) : CD 012852. DOI : 10.1002/14651858.CD012852.pub2.
P.343 掲載の参考文献
1) 伊熊慎一郎, 田中威づみ, 山口貴史ほか : 染色体異常. 産と婦 2016 ; 83 : 485-90.
2) Munne S, Scott R, Sable D, et al : First pregnancies after preconception diagnosis of translocations of maternal origin. Fertil Steril 1998 ; 69 : 675-81.
3) Sugiura-Ogasawara M, Ozaki Y, Sato T, et al : Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocation. Fertil Steril 2004 ; 81 : 367-73.
4) Stephenson MD, Sierra S : Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod 2006 ; 21 : 1076-82.
5) Franssen MT, Korevaar JC, van der Veen F, et al : Reproductive outcome after chromosome analysis in couples with two or more miscarriages : index [corrected]-control study. BMJ 2006 ; 332 : 759-63.
6) Sugiura-Ogasawara M, Aoki K, Fujii T, et al : Subsequent pregnancy outcomes in recurrent miscarriage patients with a paternal or maternal carrier of structural chromosome rearrangement. J Hum Genet 2008 ; 53 : 622-8.
7) Ozawa N, Maruyama T, Nagashima T, et al : Pregnancy outcomes of reciprocal translocation carriers who have a history of repeated pregnancy loss. Fertil Steril 2008 ; 90 : 1301-4.
8) Kochhar PK, Pranay G : Reprodutctive outcome of couples with recurrent miscarriage and balanced chromosomal abnormalities. J Obstet Gynecol Res 2013 ; 39 : 113-20.
9) Fiorentino F, Spizzichino L, Bono S, et al : PGD for reciprocal and Robertsonian translocations using array comparative genomic hybridization. Hum Reprod 2011 ; 26 : 1925-35.
10) Idown D, Merrion K, Wemmer N, et al : Pregnancy outcomes following 24-chromose preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations. Fertil Steril 2015 ; 103 : 1037-42.
11) Sato K, Sueoka K, Iino K, et al : Current status of preimplantation genetic diagnosis in Japan. Bioinformation 2015 ; 11 : 254-60.
12) Cai Y, Ding M, Diao Z, et al : Evaluation of preimplantation genetic testing based on next-generation sequencing for balanced reciprocal translocation carriers. Reprod Biomed Online 2019 ; 38 : 669-75.
13) Huang C, Jiang W, Zhu Y, et al : Pregnancy outcomes of reciprocal translocation carriers with two or more unfavorable pregnancy histories : before and after preimplantation genetic testing. J Assisted Reprod Genet 2019 ; 36 : 2325-31.
14) Bartels CB, Makhijani R, Godiwala P, et al : In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrengements comparing fluorescence comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing. F S Rep 2020 ; 1 (3) : 249-56.
15) Cheng D, Hu L, Gong F, et al : Clinical outcomes following preimplantation genetic testing and microdissecting junction region in couples with balanced chromosome rearrangement. 2021 ; 38 : 735-42.
16) Ikuma S, Sato T, Sugiura-Ogasawara M, et al : Preimplantation genetic diagnosis and natural conception : a comparison of live birth rates in patients with recurrent pregnancy loss associated with translocation. PLoS One 2015 ; 10 : e0129958.
17) Papas RS and Kutteh : Genetic testing for aneuploidy in patients who have had multiple miscarriages : A review of current literature. Appl Clin Genet 2021 ; 14 : 321-9.
18) Simon AL, Kiehl M, Fischer E, et al : Pregnancy outcomes from more than 1,800 in vitro fertilization cycles with the use of 24-chromosome single-nucleotide polymorphism-based preimplantation genetic testing for aneuploidy. Fertil Steril 2018 ; 110 : 113-21.
19) Sato T, Sugiura-Ogasawara M, Ozawa F, et al : Preimplantation genetic testing for aneuploidy : a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure. Hum Reprod 2019 ; 34 : 2340-8.
20) Munne S, Kaplan B, Frattarelli JL, et al : Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients : a multicenter randomized clinical trial. Fertil Steril 2019 ; 112 : 1071-9.
21) Zouh T, Zhu Y, Zhang J, et al : Effects of PGT-A on pregnancy outcomes for young women having one previous miscarriage with genetically abnormal products of conception. Reprod Sci 2021 ; 28 : 3265-71.
22) Bhatt SJ, Marchetto NM, Roy J, et al : Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL) : a SART-CORS study. Hum Reprod 2021 ; 36 : 2339-44.
23) 伊熊慎一郎, 田中温 : 着床前スクリーニング (preimplantation genetic screening : PGS) について. 生殖医療ポケットマニュアル, 医学書院, 2014 : 267-71.
24) Fragouli E, Alfarawati S, Daphnis DD, et al : Cytogenetic analysis of human blast cysts with the use of FISH, CGH and aCGH : scientific data and technical evaluation. Hum Reprod 2011 ; 26 : 480-90.
25) 中岡義晴 : 着床前診断. 産婦の実際 2015 ; 64 : 385-90.
26) 右田王介, 秦健一郎 : 新しい遺伝学的検査-大量遺伝子解析技術 (DNAマイクロアレイ解析, 次世代シークエンサー) とその展望-. 産婦の実際 2015 ; 64 : 315-21.
P.349 掲載の参考文献
1) Morita K, Ono Y, Takeshita T, et al : Risk factors and outcomes of recurrent pregnancy loss in Japan. J Obstet Gynaecol Res 2019 ; 45 : 1997-2006.
2) 齋藤滋 : 本邦における不育症のリスク因子とその予後に関する研究. 厚生労働省 不育症班研究, 2010.
3) Ogasawara M, Aoki K, Okada S, et al : Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000 ; 73 : 300-4.
4) Schleussner E, Kamin G, Seliger G, et al : Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss : a multicenter trial with a minimization randomization scheme. Ann Inter Med 2015 ; 162 : 601-U 193.
5) Schisterman EF, Silver RM, Lesher LL, et al : Preconception low-dose aspirin and pregnancy outcomes : results from the EAGeR randomised trial. Lancet 2014 ; 384 : 29-36.
6) Wong LF, Porter TF, Scott JR : Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2014.
7) Quenby S, Nik H, Innes B, et al : Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod 2009 ; 24 : 45-54.
8) Tang A-W, Alfirevic Z, Turner MA, et al : A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod 2013 ; 28 : 1743-52.
9) Coomarasamy A, Williams H, Truchanowicz E, et al : A Randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med 2015 ; 373 : 2141-8.
10) Coomarasamy A, Devall AJ, Brosens JJ, et al : Micronized vaginal progesterone to prevent miscarriage : a critical evaluation of randomized evidence. Am J Obstet Gynecol 2020 ; 223 : 167-76.
11) Gellersen B, Brosens JJ : Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev 2014 ; 35 : 851-905.
12) Wilcox AJ, Baird DD, Wenberg CR : Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999 ; 340 : 1796-9.
13) Teklenburg G, Salker M, Molokhia M, et al : Natural selection of human embryos : decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One 2010 ; 5.
14) Weimar CHE, Kavelaars A, Brosens JJ, et al : Endometrial stromal cells of women with recurrent miscarriage fail to discriminate between high-and low-quality human embryos. PLoS One 2012 ; 7 : e41424.
15) Brosens JJ, Salker MS, Teklenburg G, et al : Uterine selection of human embryos at implantation. Sci Rep 2014 ; 4 : 3894.
16) Teklenburg G, Salker M, Heijnen C, et al : The molecular basis of recurrent pregnancy loss : impaired natural embryo selection. Mol Hum Reprod 2010 ; 16 : 886-95.
17) Salker M, Teklenburg G, Molokhia M, et al : Natural selection of human embryos : impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One 2010 ; 5 : e10287.

各論 Q & A

P.359 掲載の参考文献
1) Behre HM, Kuhlage J, Gassner C, et al : Prediction of ovulation by urinary hormone measurements with the home use ClearPlanR Fertility Monitor : comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 2000 ; 15 : 2478-82.
2) Wilcox AJ, et al : Post-ovulatory ageing of the human oocyte and embryo failure. Hum Reprod 1998 ; 13 : 394-7.
3) Honda T, Tsutsumi M, Komoda F, et al : Acceptable pregnancy rate of unstimulated intrauterine insemination : a retrospective analysis of 17, 830 cycles. Reprod Med Biol 2015 ; 14 (1) : 27-32.
4) 大野原良晶ほか : 当院不妊外来における治療成績と年齢との関連. 鳥取医誌 2012 ; 40 : 130-5.
5) 日本産科婦人科学会 : ARTデータブック 2018.
6) Steiner AZ, Jukic AM : Impact of female age and null gravidity on fecundity in an older reproductive age cohort. Fertil Steril 2016 ; 105 : 1584-8.
7) Did percentages of ART transfers that resulted in live births differ between fresh donor and fresh nondonor eggs? Assisted Reproductive Technology National Summary Report 2013. Centers for Disease Control and Prevention 2015 : 46.
8) Seow KM, Juan CC, Hwang JL, et al : Laparoscopic Surgery in Polycystic Ovary Syndrome : Reproductive and Metabolic Effects. Semin Reprod Med 2008 ; 26 : 101-10.
P.365 掲載の参考文献
1) Kumakiri J, Takeuchi H, Itoh S, et al : Prospective evaluation for the feasibility and safety of vaginal birth after laparoscopic myomectomy. J Minim Invasive Gynecol 2008 ; 15 : 420-4.
2) Takeuchi H, Kitade M, Kikuchi I, et al : Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy. Fertil Steril 2008 ; 89 : 1247-53.
3) Kumakiri J, Kikuchi I, Kitade M, et al : Association between uterine repair at laparoscopic myomectomy and postoperative adhesions. Acta Obstet Gynecol Scand 2012 ; 91 : 331-7.
4) Kumakiri J, Takeuchi H, Kitade M, et al : Pregnancy and delivery after laparoscopic myomectomy. J Minim Invasive Gynecol 2005 ; 12 : 241-6.
5) Marret H, Fritel X, Ouldamer L, et al : Therapeutic management of uterine fibroid tumors : updated French guidelines. Eur J Obstet Gynecol Reprod Biol 2012 ; 165 : 156-64.
6) Kuroda K, Ikemoto Y, Ochiai A, et al : Combination treatment of preoperative embryo cryopreservation and endoscopic surgery (Surgery-ART Hybrid Therapy) in infertile women with diminished ovarian reserve and uterine myomas or ovarian endometriomas. J Minim Invasive Gynecol 2019 ; 26 : 1369-75.
7) 熊切順, 北出真理, 菊地盤ほか : 腹腔鏡下子宮筋腫核出術後に対するsecond-look laparoscopyの意義 : 癒着剥離術が術後自然妊娠に及ぼす影響. 日本産科婦人科内視鏡学会誌. 2013 ; 29 : 95.
8) Hachisuga T, Kawarabayashi T : Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod 2002 ; 17 : 432-5.
9) Kuroda M, Kuroda K, Arakawa A, et al : Histological assessment of impact of ovarian endometrioma and laparoscopic cystectomy on ovarian reserve. J Obstet Gynaecol Res 2012 ; 38 : 1187-93.
10) Ozaki R, Kumakiri J, Tinelli A, et al : Evaluation of factors predicting diminished ovarian reserve before and after laparoscopic cystectomy for ovarian endometriomas : a prospective cohort study. J Ovarian Res 2016 ; 9 : 37.
11) Alborzi S, Momtahan M, Parsanezhad ME, et al : A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril 2004 ; 82 : 1633-7.
12) Hart R, Hickey M, Maouris P, et al : Excisional surgery versus ablative surgery for ovarian endometriomata : a Cochrane Review. Hum Reprod 2005 ; 20 : 3000-7.
13) Marcoux S, Maheux R, Berube S, et al : Laparoscopic surgery in infertile, women with minimal or mild endometriosis. N Engl J Med 1997 ; 337 : 217-22.
14) Benschop L, Farquhar C, van der Poel N, et al : Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev 2010 ; (11) : CD008571.
15) Lukic A, Di Properzio M, De Carlo S, et al : Quality of sex life in endometriosis patients with deep dyspareunia before and after laparoscopic treatment. Arch Gynecol Obstet 2016 ; 293 : 583-90.
P.372 掲載の参考文献
1) Zepiridis LI, Grimbizis GF, Tarlatzis BC : Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2016 ; 34 : 66-73.
2) Giatras K, Noyes N, Licciardi F, et al : Fertility after hysteroscopic resection of submucous myomas. J Am Assoc Gynecol Laparosc 1999 ; 6 : 155-8.
3) Lefebvre G, Vilos G, Allaire C, et al : Clinical Practice Gynaecology Committee, Society for Obstetricians and Gynaecologists of Canada. The management of uterine leiomyomas. J Obstet Gynaecol Can 2003 ; 25 : 396-418.
4) Varasteh NN, Neuwirth RS, Levin B, et al : Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 1999 ; 94 : 168-71.
5) Preutthipan S, Herabutya Y : Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women. Fertil Steril 2005 ; 83 : 705-9.
6) Vitale SG, Haimovich S, Lagana AS, et al : From the Global Community of Hysteroscopy Guidelines Committee. Endometrial polyps. An evidence-based diagnosis and management guide. Eur J Obstet Gynecol Reprod Biol 2021 ; 260 : 70-7.
7) Practice Committee of the American Society for Reproductive Medicine : Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate : a guideline. Fertil Steril 2017 ; 3 : 416-25.
8) Kuroda K, Takamizawa S, Motoyama H, et al : Analysis of the therapeutic effects of hysteroscopic polypectomy with and without doxycycline treatment on chronic endometritis with endometrial polyps. Am J Reprod Immunol 2021 : 6.
9) Casini ML, Rossi F, Agostini R, et al : Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006 ; 22 : 106-9.
10) Stamatellos I, Apostolides A, Stamatopoulos P, et al : Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps. Arch Gynecol Obstet 2008 ; 277 : 395-9.
11) Kasuga Y, Lin BL, Kim SH, et al : The Association between Placenta Implantation at Prior Myomectomy Locations and Perinatal Outcomes in Pregnant Women Who Previously Underwent One-Step Hysteroscopic Myomectomy. Gynecol Minim Invasive Ther 2020 ; 9 : 54-8.
P.376 掲載の参考文献
1) Coronado GD, Marshall LM, Schwartz SM : Complications in pregnancy, labor, and delivery with uterine leiomyomas : A population-based study. BJOG 2000 ; 95 : 764-9.
2) Conti N, Tosti C, Pinzauti S, et al : Uterine fibroids affect pregnancy outcome in women over 30 years old : role of other risk factors. J Matern Fetal Neonatal Med 2013 ; 26 : 584-7.
3) Treissman DA, Bate JT, Randall PT : Epidural use of morphine in managing the pain of carneous degeneration of a uterine leiomyoma during pregnancy. Can Med Assoc J 1982 ; 126 : 505-6.
4) 杉本充弘, 中川潤子 : 腫瘍合併妊娠の取り扱い. 子宮筋腫. 産と婦 2001 ; 68 : 590-6.
5) Katz VL, Dotters DJ, Droegemeuller W : Complications of uterine leiomyomas in pregnancy. Obstet Gynecol 1989 ; 73 : 593-6.
6) Hasan F, Arumugam K, Sivanesaratnam V : Uterine leiomyomata in pregnancy. Int J Gynaecol Obstet 1991 ; 34 : 45-8.
7) 丸山正統, 塩田恭子, 東梅久子ほか : 子宮筋腫合併妊娠に関する臨床的検討. 日産婦学会関東連合地方部会報 1992 ; (55) : 33- 6.
8) 吉野一枝, 仁科秀則, 吉川裕之ほか : 当科における子宮筋腫合併妊娠の検討. 日産婦学会東京地方部会誌 1996 ; 45 : 81-3.
9) 石山朋美, 茂田博行, 遠藤方哉ほか : 子宮筋腫合併妊娠の検討. 産婦の実際 1999 ; 48 : 1025-9.
10) 牧野真太郎, 平井千裕, 西岡暢子ほか : 子宮筋腫合併妊娠. 産婦の実際 2009 ; 58 : 965-72.
11) Yorifuji T, Makino S, Sugimura M, et al : Time spatial labeling inversion pulse magnetic resonance angiography in pregnancy with adenomyosis. J Obstet Gynaecol Res 2013 ; 39 : 1480-3.
P.383 掲載の参考文献
1) Farquhar C : Endometriosis. BMJ 2007 ; 334 : 249-53.
2) Parazzini F : Endometriosis : prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions : results from a multicentric Italian study. Hum Reprod 1994 ; 9 : 1158-62.
3) Denny E, Mann CH : A clinical overview of endometriosis : a misunderstood disease. Br J Nurs 2007 ; 16 : 1112-6.
4) Meuleman C, Vandenabeele B, Fieuws S, et al : High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril 2009 ; 92 : 68-74.
5) Leone Roberti Maggiore U, Ferrero S, Mangili G, et al : A systematic review on endometriosis during pregnancy : diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update 2016 ; 22 (1) : 70-103.
6) Mabrouk M, Spagnolo E, Raimondo D, et al : Segmental bowel resection for colorectal endometriosis : is there a correlation between histological pattern and clinical outcomes? Hum Reprod 2012 ; 27 : 1314-9.
7) Gustofson RL, Kim N, Liu S, et al : Endometriosis and the appendix : a case series and comprehensive review of the literature. Fertil Steril 2006 ; 86 : 298-303.
8) Ueda Y, Enomoto T, Miyatake T, et al : A retrospective analysis of ovarian endometriosis during pregnancy. Fertil Steril 2010 ; 94 : 78-84.
9) Kobayashi H, Sumimoto K, Moniwa N, et al : Risk of developing ovarian cancer among women with ovarian endometrioma : a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007 ; 17 : 37-43.
10) Kobayashi H, Sumimoto K, Kitanaka T, et al : Ovarian endometrioma?Risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol 2008 ; 138 : 187-93.
11) Phupong V, Rungruxsirivorn T, Tantbirojn P, et al : Infected endometrioma in pregnancy masquerading as acute appendicitis. Arch Gynecol Obstet 2004 ; 269 : 219-20.
12) Brosens I, Fusi L, Brosens JJ : Endometriosis is a risk factor for spontaneous hemoperitoneum during pregnancy. Fertil Steril 2009 ; 92 : 1243-5.
13) Setubal A, Sidiropoulou Z, Torgal M, et al : Bowel complications of deep endometriosis during pregnancy or in vitro fertilization. Fertil Steril 2014 ; 101 : 442-6.
14) Casaubon : Sur des tumeurs sanguines a la valve. Recuel periodique de la Societe de Sante a Paris. 1797 ; 1 (An V) : 455-74.
15) Lier MC, Malik RF, Ket Johannes CF, et al : Spontaneous hemoperitoneum in pregnancy (SHiP) and endometoriosis-a systematic review of the recent literature. Eur J Obstet Gynecol Reprod Biol 2017 ; 219 : 57-65.
16) Brosens IA, Lier MC, Mijatovic V, et al : Severe spontaneous hemoperitoneum in pregnancy may be linked to in vitro fertilization in patients with endometriosis : a systematic review. Fertil Steril 2016 ; 106 : 692-703.
17) Hagimoto M, Tanaka H, Osuga Y, et al : Nationwide survey (Japan) on spontaneous hemoperitoneum in pregnancy. J Obstet Gynaecol Res 2021 ; 47 (8) : 2646-52.
18) Brosens I, Brosens JJ, Fusi L, et al : Risks of adverse pregnancy outcome in endometriosis. Fertil Steril 2012 ; 98 : 30-5.
19) Stephansson O, Kieler H, Granath F, et al : Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod 2009 ; 24 : 2341-7.
20) Vercellini P, Parazzini F, Pietropaolo G, et al : Pregnancy outcome in women with peritoneal, ovarian and rectovaginal endometriosis : a retrospective cohort study. BJOG 2012 ; 119 : 1538-43.
21) Vigano P, Corti L, Berlanda N : Beyond infertility : obstetrical and postpartum complications associated with endometriosis and adenomyosis. Fertil Steril 2015 ; 104 : 802-12.
22) Takemura Y, Osuga Y, Fujimoto A, et al : Increased risk of placenta previa is associated with endometriosis and tubal factor infertility in assisted reproductive technology pregnancy. Gynecol Endocrinol 2013 ; 29 : 113-5.
23) Kuivasaari-Pirinen P, Raatikainen K, Hippelainen M, et al : Adverse outcomes of IVF/ICSI pregnancies vary depending on aetiology of infertility. ISRN Obstet Gynecol 2012 : 451915.
24) Stephansson O, Kieler H, Granath F, et al : Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod 2009 ; 24 : 2341-7.
25) Hadfield RM, Lain SJ, Raynes-Greenow CH, et al : Is there an association between endometriosis and the risk of pre-eclampsia? A population based study. Hum Reprod 2009 ; 24 : 2348-52.
26) Healy DL, Breheny S, Halliday J, et al : Prevalence and risk factors for obstetrics haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia. Hum Reprod 2010 ; 25 : 265-74.
27) Kuivasaari-Pirinen P, Raatikainen K, Hippelainen M, et al : Adverse outcomes of IVF/ICSI Pregnancies vary depending on aetiology of infertility. ISRN Obstet Gynecol 2012 ; 2012 : 451915.
28) Aris A : A 12-year cohort study on adverse pregnancy outcomes in Eastern Townships of Canada : impact of endometriosis. Gynecol Endocrinol 2014 ; 30 : 34-7.
29) Conti N, Cevenini G, Vannuccini S, et al : Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome. J Matern Fetal Neonatal Med 2015 ; 28 : 1795-8.
30) Mekaru K, Masamoto H, Sugiyama H, et al : Endometriosis and pregnancy outcome : are pregnancies complicated by endometriosis a high-risk group? Eur J Obstet Gynecol Reprod Biol 2014 ; 172 : 36-9.
31) Stern JE, Luke B, Tobias M, et al : Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment. Fertil Steril 2015 ; 103 : 1438-45.
32) Lin H, Leng JH, Liu JT, et al : Obstetric outcomes in Chinese women with endometriosis : a retrospective cohort study. Chin Med J (Engl) 2015 ; 128 : 455-8.
P.389 掲載の参考文献
1) 竹田純, 牧野真太郎, 平井千裕ほか : 当院における腹腔鏡下子宮筋腫核出術後妊娠の管理. 日産婦内視鏡会誌 2015 ; 31 : 114.
2) 竹田省 : 妊産婦死亡 "ゼロ" への挑戦. 日産婦会誌2016 ; 68 : 345-6.
3) 竹田純ほか : 周産期管理がぐっとうまくなる! ハイリスク妊娠の外来診療パーフェクトブック 9 婦人科疾患. 産婦の実際 (増刊号) 2016 ; 65 : 1435-42.
4) Gambacorti-Passerini Z, Gimovsky AC, Locatelli A, et al : Trial of labor after myomectomy and uterine rupture : a systematic review. Acta Obstet Gynecol Scand 2016 ; 95 : 724-34.
5) 牧野真太郎 : 分娩・産褥期の最上と異常/周産期感染症 : 産科危機的出血の管理. Science and Practice産科婦人科臨床シリーズ 3. 藤井知行編, 2021, 中山書店, p. 183-194.
6) Makino S, Takeda S, Kondoh E, et al : National survey of uterine rupture in Japan : Annual report of Perinatology Committee, Japan Society of Obstetrics and Gynecology, 2018. J Obstet Gynaecol Res 2019 ; 45 : 763-5.
7) 日本産科婦人科学会/日本産婦人科医会編 : CQ403 帝王切開既往妊婦が経腟分娩 (TOLAC, trial of labor after cesarean delivery) を希望した場合は? 産婦人科診療ガイドライン 産科編 2020, p 199-201.
8) Thiravit S, Ma K, Goldman I, et al : Role of ultrasound and MRI in diagnosis of severe placenta accrete spectrum disorder : An intraindividual assessment with emphasis on placental bulge. AJR Am J Roentgenol 2021 ; 217 (6) : 1377-88.
9) 竹田純 : 子宮筋腫核出術後の (常位) 癒着胎盤. OGS NOW Basic 9, 竹田省ほか編, メジカルビュー社, 2021, p. 60-69.
10) 松永茂剛, 村山敬彦, 関博之 : 子宮筋腫核出術後の癒着胎盤の子宮温存法. OGS NOW 22 手術を要する産婦人科救急-こんなときどうする? 竹田省ほか編, メジカルビュー社, 2015, p 68-81.
P.395 掲載の参考文献
1) Kuroda K, Ikemoto Y, Ochiai A, et al : Combination Treatment of Preoperative Embryo Cryopreservation and Endoscopic Surgery (Surgery-ART Hybrid Therapy) in Infertile Women with Diminished Ovarian Reserve and Uterine Myomas or Ovarian Endometriomas. J Minim Invasive Gynecol 2019 ; 26 : 1369-75.
2) Sunkara SK, Rittenberg V, Raine-Fenning N, et al : Nomogram for predicting live birth from egg number : an analysis of 400, 135 IVF cycles. Hum Reprod 2011 ; 26 : I 34.
3) Ishihara O, Jwa SC, Kuwahara A, et al : Assisted reproductive technology in Japan : A summary report for 2017 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol 2019 ; 19 : 3-12.
4) Takeuchi H, Kuwatsuru R : The indications, surgical techniques, and limitations of laparoscopic myomectomy. JSLS 2003 ; 7 : 89-95.
P.402 掲載の参考文献
1) Harada T, Iwabe T, Terakawa N : Role of cytokines in endometriosis. Fertil Steril 2001 ; 76 : 1-10.
2) Kuroda K, Ikemoto Y, Ochiai A, et al : Combination treatment of preoperative embryo cryopreservation and endoscopic surgery (Surgery-ART Hybrid Therapy) in infertile women with diminished ovarian reserve and uterine myomas or ovarian endometriomas. J Minim Invasive Gynecol 2019 ; 26 : 1369-75.
3) Marcoux S, Maheux R, Berube S, et al : Laparoscopic surgery in infertile, women with minimal or mild endometriosis. N Engl J Med 1997 ; 337 : 217-22.
4) Alborzi S, Momtahan M, Parsanezhad ME, et al : A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril 2004 ; 82 : 1633-7.
5) Hart R, Hickey M, Maouris P, et al : Excisional surgery versus ablative surgery for ovarian endometriomata : a Cochrane Review. Hum Reprod 2005 ; 20 : 3000-7.
6) Demirol A, Guven S, Baykal C, et al : Effect of endometrioma cystectomy on IVF outcome : a prospective randomized study. Reprod Biomed Online 2006 ; 12 : 639-43.
7) Garcia-Velasco JA, Arici A : Surgery for the removal of endometriomas before in vitro fertilization does not increase implantation and pregnancy tests. Fertil Steril 2004 ; 81 : 1206.
8) Benschop L, Farquhar C, van der Poel N, et al : Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev 2010 ; 11 : CD008571.
9) Tummon IS, Asher LJ, Martin JS, et al : Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril 1997 ; 68 : 8-12.
10) Vercellini P, Consonni D, Dridi D, et al : Uterine adenomyosis and in vitro fertilization outcome : a systematic review and meta-analysis. Hum Reprod 2014 ; 29 : 964-77.
11) Martinez-Conejero JA, Morgan M, Montesinos M, et al : Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation. Fertil Steril 2011 ; 96 : 943-U 401.
12) Juang CM, Chou P, Yen MS, et al : Adenomyosis and risk of preterm delivery. BJOG 2007 ; 114 : 165-9.
13) Grimbizis GF, Mikos T, Tarlatzis B : Uterus-sparing operative treatment for adenomyosis. Fertil Steril 2014 ; 101 : 472-87.
P.409 掲載の参考文献
1) Macgregor AH, Johnson JE, Bunda CA : Further clinical experience with clomiphene criteria. Fertil Steril 1968 ; 19 : 616.
2) Ares-Serono. A Phase III, open, randomized, multicentre study to compare the safety and efficacy of recombinant human FSH administered subcutaneously with that of Urinary Human Follicle stimulating hormone. Given intramuscularly, to induce ovulation in WHO Group II anovulatory infertile women. Ares-Serono, Internal Report.
3) Homburg R, Howles CM : Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome : rationale, results, reflections and refinements. Hum Reprod Update 1999 ; 5 : 493-9.
4) Seow KM, Juan CC, Hwang JL et al : Laparoscopic surgery in polycystic ovary syndrome ; reproductive and metabolic effects. Semin Reprod Med 2008 ; 26 : 101.
5) The Thessaloniki ESHRE/ASRM-sponsored PCOS consensus workshop group : Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008 ; 89 : 505-22.
6) Abu Hashim H : Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome : an evidence-based approach. Arch Gynecol Obstet 2015 ; 291 : 11-8.
7) Amer SA, Banu Z, Li TC et al : Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling : endocrine and ultrasonographic outcomes. Hum Reprod 2002 ; 17 : 2851-7.
8) Nahuis MJ, Kose N, Bayram N, et al : Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. Hum Reprod 2011 ; 26 : 1899-904.
P.416 掲載の参考文献
1) Webber L, Davies M, Anderson R, et al : ESHRE Guideline : management of women with premature ovarian insufficiency. Hum Reprod 2016 ; 31 : 926-37.
2) Golezar S, Ramezani Tehrani F, et al : The global prevalence of primary ovarian insufficiency and early menopause : a meta-analysis. Climacteric 2019 ; 22 : 403-11.
3) Dragojevic-Dikic S, Rakic S, Nikolic B, et al : Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure. Gynecol Endocrinol 2009 ; 25 : 769-72.
4) Vandborg M, Lauszus FF : Premature ovarian failure and pregnancy. Arch Gynecol Obstet 2006 ; 273 : 387-8.
5) Laml T, Huber JC, Albrecht AE, et al : Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrhea. Gynecol Endocrinol 1999 ; 13 : 89-92.
6) Bidet M, Bachelot A, Bissauge E, et al : Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011 ; 96 : 3864-72.
7) Faddy MJ, Gosden RG, Gougeon A, et al : Accelerated disappearance of ovarian follicles in mid-life : implications for forecasting menopause. Hum Reprod 1992 ; 7 : 1342-6.
8) Fenton AJ : Premature ovarian insufficiency : Pathogenesis and management. J Midlife Health 2015 ; 6 : 147-53.
9) Polyzos NP, Devroey P : A systematic review of randomized trials for the treatment of poor ovarian responders : is there any light at the end of the tunnel? Fertil Steril 2011 ; 96 : 1058-U 253.
10) Galey-Fontaine J : Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online 2005 ; 10 : 94-9.
11) Kuroda K, Kitade M, Kumakiri J, et al : Minimum ovarian stimulation involving combined clomiphene citrate and estradiol treatment for in vitro fertilization of Bologna-criteria poor ovarian responders. J Obstet Gynaecol Res 2016 ; 42 : 178-83.
12) Hajipour H, Farzadi L, Latifi Z, et al : An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities : clinical and molecular aspects. Syst Biol Reprod Med 2021 ; 67 : 177-88.
13) Cakiroglu Y, Saltik A, Yuceturk A, et al : Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging 2020 ; 12 : 10211-22.
14) Umehara T, Urabe N, Obata T, et al : Cutting the ovarian surface improves the responsiveness to exogenous hormonal treatment in aged mice. Reprod Med Biol 2020 ; 19 : 415-24.
15) Tatone C, Di Emidio G, Barbonetti A, et al : Sirtuins in gamete biology and reproductive physiology : emerging roles and therapeutic potential in female and male infertility. Hum Reprod Update 2018 ; 24 : 267-89.
16) Neves AR, Lucio M, Lima JL, et al : Resveratrol in medicinal chemistry : a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 2012 ; 19 : 1663-81.
17) Ochiai A, Kuroda K, Ozaki R, et al : Resveratrol inhibits decidualization by accelerating downregulation of the CRABP 2-RAR pathway in differentiating human endometrial stromal cells. Cell Death Dis 2019 ; 10 : 276.
18) Brighton PJ, Maruyama Y, Fishwick K, et al : Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium. Elife 2017 ; 6 : e31274.
19) Ochiai A, Kuroda K, Ikemoto Y, et al : Influence of resveratrol supplementation on IVF-embryo transfer cycle outcomes. Reprod Biomed Online 2019 ; 39 : 205-10.
20) Kuroda K, Ochiai A, Brosens JJ : The actions of resveratrol in decidualizing endometrium : acceleration or inhibition?. Biol Reprod 2020 ; 103 : 1152-6.
21) Ochiai A, Kuroda K : Preconception resveratrol intake against infertility : Friend or foe? Reprod Med Biol 2019 ; 19 : 107-13.
22) Gerli S, Della Morte C, Ceccobelli M, et al : Biological and clinical effects of a resveratrol-based multivitamin supplement on intracytoplasmic sperm injection cycles : a single-center, randomized controlled trial. J Matern Fetal Neonatal Med 2021 : 1-9.
P.422 掲載の参考文献
1) Dessole S, Meloni GB, Capobianco G, et al : A second hysterosalpingography reduces the use of selective technique for treatment of a proximal tubal obstruction. Fertil Steril 2000 ; 73 : 1037-9.
2) Swart P, Mol BW, van der Veen F, et al : The accuracy of hysterosalpingography in the diagnosis of tubal pathology : a meta-analysis. Fertil Steril 1995 ; 64 : 486-91.
3) Tanaka Y, Tajima H, Sakuraba S, et al : Renaissance of surgical recanalization for proximal fallopian tubal occlusion : falloposcopic tuboplasty as a promising therapeutic option in tubal infertility. J Minim Invasive Gynecol 2011 ; 18 : 651-9.
4) Hou HY, Chen YQ, Li TC, et al : Outcome of laparoscopy-guided hysteroscopic tubal catheterization for infertility due to proximal tubal obstruction. J Minim Invasive Gynecol 2014 ; 21 : 272-8.
5) Capmas P, Suarthana E, Tulandi T : Management of Hydrosalpinx in the Era of Assisted Reproductive Technology : A Systematic Review and Meta-analysis. J Minim Invasive Gynecol 2021 ; 28 : 418-41.
6) Harb H, Al-Rshoud F, Karunakaran B, et al : Hydrosalpinx and pregnancy loss : a systematic review and meta-analysis. Reprod Biomed Online 2019 ; 38 : 427-41.
7) Taylor RC, Berkowitz J, McComb PF : Role of laparoscopic salpingostomy in the treatment of hydrosalpinx. Fertil Steril 2001 ; 75 : 594-600.
8) Tsiami A, Chaimani A, Mavridis D, et al : Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer : a network meta-analysis. Ultrasound Obstet Gynecol 2016 ; 48 : 434-45.
9) Wu S, Zhang Q, Li Y : Effect comparison of salpingectomy versus proximal tubal occlusion on ovarian reserve : A meta-analysis. Medicine (Baltimore) 2020 ; 99 : e20601.
10) Holzer I, Ott J, Kurz C, et al : Is Chronic Endometritis Associated with Tubal Infertility? A Prospective Cohort Study. J Minim Invasive Gynecol 2021 ; 28 (11) : 1876-81.
P.427 掲載の参考文献
1) Somigliana E PA, Busnelli A, Filippi F, et al : Age-related infertility and unexplained infertility : an intricate clinical dilemma. Hum Reprod 2016 ; 31 : 1390-6.
2) Veltman-Verhulst SM, Hughes E, Ayeleke RO, et al : Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2016 ; 2 : CD001838.
3) Marcoux S, Maheux R, Berube S, et al : Laparoscopic surgery in infertile, women with minimal or mild endometriosis. N Engl J Med 1997 ; 337 : 217-22.
4) Tanahatoe SJ, Hompes PG, Lambalk CB : Investigation of the infertile couple : Should diagnostic laparoscopy be performed in the infertility work up programme in patients undergoing intrauterine insemination? Hum Reprod 2003 ; 18 : 8-11.
5) Fertility : Assessment and Treatment for People with Fertility Problems. NICE Clinical Guidelines, No. 156, National Collaborating Centre for Women's and Children's Health 2013 ; 63.
P.436 掲載の参考文献
1) Ishihara O, Jwa SC, Kuwahara A, et al : Assisted reproductive technology in Japan : A summary report for 2017 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol 2019 ; 9 : 3-12.
2) La Vignera S, Condorelli RA, Balercia G, et al : Does alcohol have any effect on male reproductive function? A review of literature. Asian J Androl 2013 ; 5 : 221-5.
2) Kuroda K, Yamashita S : Implantation Failure 1 : Intrauterine Circumstances and Embryo-Endometrium Synchrony at Implantation. In : Kuroda K, Brosens JJ, Quenby S, Takeda S, eds : Treatment Strategy for Unexplained Infertility and Recurrent Miscarriage, Singapore : Springer Singapore, 2018, p 33-43.
3) Bouet PE, El Hachem H, Monceau E, et al : Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure : prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril 2016 ; 105 : 106-10.
3) Sharma R, Harlev A, Agarwal A, et al : Cigarette Smoking and Semen Quality : A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen. Eur Urol 2016 ; 70 : 635-45.
4) Moreno I, Codoner FM, Vilella F, et al : Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol 2016 ; 215 : 684-703.
4) Iwamoto T, Nozawa S, Yoshiike M, et al : Semen quality of fertile Japanese men : a cross-sectional population-based study of 792 men. BMJ Open 3 : pii : e002223. doi : 10.1136/bmjopen-2012-002223, 2013.
5) Kadogami D, Nakaoka Y, Morimoto Y : Use of a vaginal probiotic suppository and antibiotics to influence the composition of the endometrial microbiota. Reprod Biol 2020 ; 20 : 307-14.
5) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. World Health Organization. Cambridge University Press, 1999.
6) Tan J, Kan A, Hitkari J, et al : The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers. J Assist Reprod Genet 2018 ; 35 : 683-92.
6) Blickenstorfer K, Voelkle M, Xie M, et al : Are WHO Recommendations to Perform 2 Consecutive Semen Analyses for Reliable Diagnosis of Male Infertility Still Valid? J Urol 2019 ; 201 : 783-91.
7) ElSheikh MG, Hosny MB, Elshenoufy A, et al : Combination of vitamin E and clomiphene citrate in treating patients with idiopathic oligoasthenozoospermia : A prospective, randomized trial. Andrology 2015 ; 3 : 864-7.
7) Neves AR, Devesa M, Martinez F, et al : What is the clinical impact of the endometrial receptivity array in PGT-A and oocyte donation cycles? J Assist Reprod Genet 2019 ; 36 : 1901-8.
8) Kuroda K, Horikawa T, Moriyama A, et al : Impact of chronic endometritis on endometrial receptivity analysis results and pregnancy outcomes. Immun Inflamm Dis 2020 ; 8 : 650-8.
9) Mekinian A, Cohen J, Alijotas-Reig J, et al : Unexplained Recurrent Miscarriage and Recurrent Implantation Failure : Is There a Place for Immunomodulation? Am J Reprod Immunol 2016 ; 76 : 8-28.
10) Johnston-MacAnanny EB, Hartnett J, Engmann LL, et al : Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril 2010 ; 93 : 437-41.
11) Kuroda K, Takamizawa S, Motoyama H, et al : Analysis of the therapeutic effects of hysteroscopic polypectomy with and without doxycycline treatment on chronic endometritis with endometrial polyps. Am J Reprod Immunol 2021 ; 85 : e13392.
12) Yanaihara A, Yorimitsu T, Motoyama H, et al : Location of endometrial polyp and pregnancy rate in infertility patients. Fertil Steril 2008 ; 90 : 180-2.
13) Tanimura S, Funamoto H, Hosono T, et al : New diagnostic criteria and operative strategy for cesarean scar syndrome : Endoscopic repair for secondary infertility caused by cesarean scar defect. J Obstet Gynaecol Res 2015 ; 41 : 1363-9.
14) Nakagawa K, Kwak-Kim J, Ota K, et al : Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood Th 1/Th 2 cell ratios. Am J Reprod Immunol 2015 ; 73 : 353-61.
15) Boomsma CM, Keay SD, Macklon NS : Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012 ; (6) : CD005996.
16) Fabris A, Pacheco A, Cruz M, et al : Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients. Fertil Steril 2014 ; 102 : 1608-12.
17) Ikemoto Y, Kuroda K, Nakagawa K, et al : Vitamin D Regulates Maternal T-Helper Cytokine Production in Infertile Women. Nutrients 2018 ; 10 : 902.
18) Kuroda K, Matsumura Y, Ikemoto Y, et al : Analysis of the risk factors and treatment for repeated implantation failure : OPtimization of Thyroid function, Immunity, and Uterine Milieu (OPTIMUM) treatment strategy. Am J Reprod Immunol 2021 ; 85 : e13376.
19) Nastri CO, Lensen SF, Gibreel A, et al : Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database Syst Rev 2015 ; (3) : CD009517.
20) Maleki-Hajiagha A, Razavi M, Rouholamin S, et al : Intrauterine infusion of autologous platelet-rich plasma in women undergoing assisted reproduction : A systematic review and meta-analysis. J Reprod Immunol 2020 ; 137 : 103078.
P.443 掲載の参考文献
1) Tsujimura A, Hiramatsu I, Nagashima Y, et al : Erectile dysfunction is predictive symptom for poor semen in newlywed men in Japan. Sex Med 2020 ; 8 : 21-9.
P.454 掲載の参考文献
1) 田中温ほか : 当院における過去16年間の無精子症患者の治療成績. 第34 回日本受精着床学会・学術集会. 2016-0915/16. p. 180.
2) 中堀豊, 李周遠, Ewis AA ほか : Y染色体の多様性と男性表現型の関連. 蛋白質・核酸・酵素 2001 ; 46 : 2346-50.
3) 森崇英, 久保春海, 岡村 均ほか : 図説ARTマニュアル. p. 321-8, 永井書店 (大阪), 2002.
4) 粟田松一郎, 田中温, 永吉基ほか : 無精子症患者への対応. 産婦の世界 2004 ; 56 : 229-37.
5) Okada H, Tajima A, Shichiri K, et al : Genome-wide expression of azoospermia testes demonstrates a specific profile and implicates ART 3 in genetic susceptibility. PLoS Genet 2008 ; 4 : e26.
6) Tanaka A, Nagayoshi M, Takemoto Y, et al : Fourteen babies born after round spermatid injection into human oocytes. Proc Natl Acad Sci USA 2015 ; 112 : 14629-34.
7) Patrizio P, Silber S, Ord T, et al : Two births after microsurgical sperm aspiration in congenital absence of vas deferens. Lancet 1988 ; 2 : 1364.
8) Palermo G, Joris H, Devroey P, et al : Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992 ; 340 : 17-8.
9) Schlegel PN, Palermo GD, Goldstein M, et al : Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia. Urology 1997 ; 49 : 435-40.
10) Ohno M, Tanaka A, Nagayoshi M, et al : Modified permeable cryoprotectant-free vitrification method for three or fewer ejaculated spermatozoa from cryptozoospermic men and 7-year follow-up study of 14 children born from this method. Human Reproduction 2020 ; 35 (5) : 1019-28.
P.460 掲載の参考文献
1) Panesar NS, Li CY, Rogers MS : Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem 2001 ; 38 : 329-32.
2) Morreale de Escobar G, Obregon MJ, Escobar del Rey F : Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000 ; 85 : 3975-87.
3) Velkeniers B, Van Meerhaeghe A, Poppe K, et al : Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies : systematic review and meta-analysis of RCTs. Hum Reprod Update 2013 ; 19 : 251-8.
4) Cramer DW, Sluss PM, Powers RD, et al : Serum prolactin and TSH in an in vitro fertilization population : is there a link between fertilization and thyroid function? J Assist Reprod Genet 2003 ; 20 : 210-5.
5) Colicchia M, Campagnolo L, Baldini E, et al : Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update 2014 ; 20 : 884-904.
6) Fedail JS, Zheng K, Wei Q, et al : Roles of thyroid hormones in follicular development in the ovary of neonatal and immature rats. Endocrine 2014 ; 46 : 94-604.
7) Mekaru K, Kamiyama S, Masamoto H, et al : Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium. Gynecol Endocrinol 2008 ; 24 : 498-501.
8) van den Boogaard E, Vissenberg R, Land JA, et al : Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy : a systematic review. Hum Reprod Update 2011 ; 17 : 605-19.
9) Haddow JE, Palomaki GE, Allan WC, et al : Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999 ; 341 : 549-55.
10) Alexander EK, Pearce EN, Brent GA, et al : 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 2017 ; 27 : 315-89.
11) Kaneshige T, Arata N, Harada S, et al : Changes in serum iodine concentration, urinary iodine excretion and thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium (lipiodol). J Clin Endocrinol Metab 2015 ; 100 : E 469-72.
P.465 掲載の参考文献
1) Vogt E, Ng AK, Rote NS : A model for the antiphospholipid antibody syndrome : monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996 ; 174 : 700-7.
2) Sugimura M, Kobayashi T, Shu F, et al : Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta 1999 ; 20 : 555-60.
3) Shu F, Sugimura M, Kanayama N, et al : Imunohistochemical study of annexin V expression in placentae of preeclampsia. Gynecol Obstet Invest 2000 ; 49 : 17-23.
4) Simcox LE, Ormesher L, Tower C, et al : Thrombophilia and Pregnancy Complications. Int J Mol Sci 2015 ; 16 : 28418-28.
5) Hamulyak EN, Scheves LJJ, Marijsen MC, et al : Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane database Syst Rev 2020 ; 5 (5) : CD012852.
P.471 掲載の参考文献
1) Ogasawara M, Aoki K, Okada S, et al : Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000 ; 73 : 300-4.
2) Morita K, Ono Y, Takeshita T, et al : Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan. J Obstet Gynaecol Res 2019 ; 45 : 1997-2006.
3) Lund M, Kamper-Jorgensen M, Nielsen HS, et al : Prognosis for live birth in women with recurrent miscarriage ; what is the best measure of success? Obstet Gynecol 2012 ; 119 : 37-43.
4) 日本産科婦人科学会・日本産婦人科医会編 : CQ204 反復・習慣流産患者の診断と取り扱いは? 産婦人科診療ガイドライン-産科編 2014, 日本産科婦人科学会, 2014, p 119-24.
P.476 掲載の参考文献
1) Rienzi L, Cobo A, Paffoni A, et al : Consistent and predictable delivery rates after oocyte vitrification ; an observational longitudinal cohort multicentric study. Hum Reprod 2012 ; 27 : 1606-12.
2) The Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology : Mature oocyte cryopreservation : a guideline. Fertil Steril 2013 ; 99 : 37-43.
3) ESHRE Task Force on Ehtics and Law ; Dondorp W, de Wert G, Pennings G, et al : Oocyte cryopreservation for age-related fertility loss. Hum Reprod 2012 ; 27 : 1231-7.
4) Donnez J, Dolmans MM, Demylle D, et al : Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004 ; 364 : 1405-10.
5) Kikuchi I, Kagawa N, Silber S, et al : Oophorectomy for Fertility Preservation via Reduced-Port Laparoscopic Surgery. Surg Innov 2013 ; 20 : 219-24.
6) Cobo A, Garcia-Velasco JA : Why all women should freeze their eggs. Curr Opin Obstet Gynecol 2016 ; 28 : 206-10.
7) Devine K, Mumford SL, Goldman KN, et al : Baby budgeting : oocyte cryopreservation in women delaying reproduction can reduce cost per live birth. Fertil Steril 2015 ; 103 : 1446-53.
P.483 掲載の参考文献
1) 日本産科婦人科学会倫理委員会 : 「着床前診断」に関する見解. 日産婦誌 2018 ; 70 : 1584-85.
2) 中岡義晴 : 着床前診断の進歩. 産と婦 2016 ; 83 : 802-9.
3) 日本産科婦人科学会 : 倫理委員会 着床前診断に関する審査小委員会報告. 日産婦誌 2017 ; 69 : 1916-20.
4) 日本産科婦人科学会/日本産婦人科医会 : CQ106-1 妊娠初期・中期に胎児の異常が心配と相談があった場合には? 産婦人科診療ガイドライン-産科編 2020 : 79-81.
5) Mastroiacovo P, Botto LD, Cavalcanti DP, et al : Limb anomalies following chorionic villi sampling : a registry based case-control study. Am J Med Genet 1992 ; 44 : 854-64.
6) 日本産科婦人科学会倫理委員会 : 母体血を用いた出生前遺伝学的検査に関する指針. 日産婦誌 2013 ; 65 : 1218-25.
7) Salomon LJ, Alfirevic Z, Bilardo CM, et al : ISUOG practice guidelines : performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2013 ; 41 : 102-13.
8) Snijders RJM, Noble P, Sebire N, et al : UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nucal-translucency thickness at 10-14 weeks of gestation. Lancet 1998 ; 351 : 343-6.
P.497 掲載の参考文献
1) 才村真理 : 生殖補助医療で生まれた子どもの出自を知る権利. 福村出版, 東京, 2008.

最近チェックした商品履歴

Loading...